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ABSTRACT 
Mycobacterium paratuberculosis transcriptional and translational 
signals were studied to gain insight into gene expression in this 
organism. To study M. paratuberculosis promoter structures, a more 
versatile promoter selection vector was constructed from the pKOl 
parent vector. This new plasmid, pJJ2, was used to identify 11 
promoter fragments from an M. paratuberculosis DNA library. In 
addition, a previously characterized M. paratuberculosis promoter, 
contained in a 493-bp fcoRI fragment, was cloned into the new vector 
to test the efficacy in cloning novel M. paratuberculosis promoters. In a 
related study, an expression probe shuttle plasmid (pYUB76) was 
employed to clone M. paratuberculosis expression signals that could be 
studied directly in mycobacteria. Using this vector to identify M. 
paratuberculosis expression signals, we have determined the nucleotide 
sequence of ten promoter-containing fragments cind have compared 
these sequences to those of several previously reported Mycobacterium 
promoters. Hexanucleotide sequences centered approximately 35 and 
10 base pairs upstream from the experimentally determined 
transcription start sites revealed a consensus that is different from E. 
coli. Compilation of these promoter sequences identified the -35 (T, 
T/G, G, A/C, G, T) and the -10 (C, A, G, C, C, G) conserved hexanucleotides. 
1 
GENERAL INTRODUCTION 
Objective 
Mycobacterium paratuberculosis is tlie etiologic agent of 
paratuberculosis, a chronic intestinal granulomatous infection of 
domestic or captive ruminants characterized by multiplication of the 
organisms within macrophages in the intestinal mucosa (Chiodini et 
al., 1984; Merkal 1984; Thoen and Baum, 1988). A detailed study of 
the molecular basis of pathogenesis in M. paratuberculosis is crucial 
to the understanding of the organism's ability to survive within host 
macrophages as well as to gain insight for vaccine development. The 
transcriptional machinery of mycobacteria in general, and M. 
paratuberculosis in particular, has not been well defined. M. 
paratuberculosis is seldom included in studies of this genus because 
of its extremely slow growth and culture difficulties. Moreover, the 
potential health hazard associated with its manipulation may have 
deterred many workers, Mycobacteria are among the most difficult 
prokaryotes to lyse due to the thick, lipid-rich composition of their 
cell walls. Chemical or enzymatic lysis is relatively tedious and 
requires long incubation periods. Moreover, mechanical disruption 
often results in incomplete lysis (Hurley etal., 1987; Hines etal., 
1991). Thus, M. paratuberculosis remains an underdeveloped 
genetic system. To date, only four genes have been cloned and 
sequenced (Stevenson etal., 1991; Gilot etal., 1993; Green etal.. 
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1989; Hance etal., 1989) and only two promoters have been 
characterized in this species (Murray etal., 1992; Thomas etal., 
1992). A method of genetic exchange has only recently been 
established (Foley-Thomas etal, 1995). By contrast, there are well 
over 150 characterized Escherichia coli promoters that have been 
assembled and analyzed in detail (O'Neill, 1989). 
It was against this background that the project of cloning M. 
paratuberculosis promoters was undertaken. The focus was to 
extend the current knowledge of promoter architecture and gene 
expression in M. paratuberculosis by characterizing additional 
promoter elements with the long range goal of adapting this 
organism to the IVET {in vivo expression technology) method 
recently developed (Mekalanos, 1992; Mahan etal., 1993) and 
refined (Mahan etal., 1995) in the laboratory of John Mekalanos. 
Therefore, this project represents an initial step, that being the 
cloning and characterization of M. paratuberculosis promoters, with 
the ultimate goal of acquiring the ability to search for 
environmentally induced changes in mycobacterial gene expression 
which may provide clues to virulence mechanisms. Furthermore, a 
thorough analysis of M. paratuberculosis expression sequences was 
undertaken with the goal of cloning a strong promoter to optimize 
the expression of foreign antigens in Mycobacterium bovis BCG 
(Barletta etal., 1990). 
Initial studies were aimed at improving upon the promoter-
probe vector pKOl and using it to examine mycobacterial 
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transcription signals in E. coli. One novel promoter-containing M. 
paratuberculosis DNA fragment was cloned and sequenced with the 
modified pKOl vector (pJJ2). In addition, a previously characterized 
M. paratuberculosis promoter (Thomas etal., 1992) was cloned into 
pJJ2 to show that modifications to the vector did not affect the galK 
reporter gene functions. This resulting construct, designated pTBlO, 
was further characterized by subcloning and transcription start site 
mapping. These studies were abandoned when another promoter-
probe vector, pYUB76 (Barletta etal., 1992), became available which 
could replicate in both E. coli and Mycobacterium smegmatis hosts. 
This allowed transcription initiation studies to be performed directly 
in mycobacteria. To perform these studies, a M. paratuberculosis 
DNA library was cloned into the promoter-probe shuttle vector 
pYUB76. This vector contains a promoterless lacZ gene that serves as 
the reporter gene in mycobacteria and E. coli. Over 100 promoter-
containing clones were identified after electroporation of the library 
into E. coli DHIOB. Identification was based on lacZ (which encodes 
p-galactosidase) expression on Xgal containing media. In one 
experiment, 12 lacZ positive colonies were selected, minipreped and 
used to electrotransform M. smegmatis mc^l55. Then a comparitive 
analysis of expression levels between the two surrogate hosts was 
quantitatively assessed. It was observed that when the reporter 
gene was expressed at high levels in one host, expression in the other 
host was only transient. Thus it was concluded that there is a 
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divergence in the transcriptional signals between E. coli and 
mycobacteria. In another experiment, that same 
library in E coli DHIOB was pooled and electroporated into M 
smegmatis. Only 24 lacZ positive colonies were obtained from this 
experiment of which the 10 strongest were sequenced. Computer 
analysis of the resulting sequences showed no strong homologies in 
the databases using default search parameters. Putative open 
reading frames were identified. Total cell RNA was extracted from 
M. smegmatis harboring the selected lacZ positive constructs and 
transcriptional activity was quantitated using slot blot analysis 
techniques. In addition the 5' mRNA start sites were identified by 
primer extension analysis and nucleotide sequences were aligned 
relative to the start sites. Based on these data, rudimentary 
consensus promoter sequences were identified. 
Dissertation organization 
The research data in this dissertation are presented in the form 
in which they are to be submitted for publication. Chapter 2 will be 
submitted to the journal Gene and Chapter 3 will be submitted to the 
Journal of Bacteriology. The literature review section, Chapter 1, is 
intended to provide a general understanding of the progress made in 
gene expression studies for mycobacteria relative to E. coli, a well 
developed system. Citations from Chapter 1 are listed at the end of 
the dissertation, whereas the citations from Chapter 2 and 3 are 
5 
listed at the end of the respective chapters. Following the last paper 
(Chapter 3) is a general conclusions section that summarizes the 
research results and provides a perpectus of future research in the 
field of mycobacterial gene expression. 
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CHAPTER 1. LITERATURE REVIEW 
Introduction 
The mycobacteria fall into two general catagories based on 
their growth rates. The fast growing mycobacteria, consisting of such 
strains as M. fortuitum, M. phlei, and M. smegmatis, have doubling 
times of 2-3 h and will produce a colony from a single cell in 3-4 
days (Wayne and Kubica, 1986). In contrast, the slow-growing 
mycobacteria such as M. avium, M. bovis, M. tuberculosis, and M. 
paratuberculosis species double every 18-26 h and thus yield 
colonies from single cells in 14-28 days. The slow growing 
mycobacteria are typically pathogenic whereas the fast growing 
strains are considered saprophytes. Interestingly, the slow growing 
mycobacteria possess a rRNA operon in single copy and the faster 
growing species have two copies (Bercovier etal., 1986). Bercovier 
et ai. (1986) used a copy of the E. coli rRNA operon as a probe in 
hybridization experiments with chromosomal DNA from two fast-
growing strains and four slow growing mycobacteria. E. coli, one of 
the faster growing prokaryotes has seven rRNA operon copies. 
M. paratuberculosis is a slow-growing, acid-fast bacterium that 
often survives in the immediate environment, especially in the feces 
of ruminants (Thoen and Baum, 1988). M. paratuberculosis requires 
1 to 2 months to isolate on primary culture, and requires an iron 
chelating compound called mycobactin (Merkal and Curran, 1974; 
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j0rgensen 1982). The mycobactin requirement exists in other slow-
growing strains of Mycobacterium (i. e. M. avium and M 
intracellulare) and was first thought to be a characteristic of 
pathogenic mycobacteria. It was later discovered that some strains 
simply do not produce enough mycobactin and therefore must aquire 
it exogenously (Merkal and McCullough, 1982). 
Johne's disease is the cause of reduced milk production and 
survival in cattle, sheep, goats and other ruminant animals (Thoen 
and Baum, 1988). The disease is prevalent in parts of the U. S. 
(Merkal et al., 1987; Thoen and Baum, 1988) and has been reported 
in countries throughout the world (Chiodini etal., 1984; NcNab eta/., 
1991). Economic losses for the U. S. dairy industry exceed 1.5 billion 
annually (Cocito etal., 1994). Mycobacterium paratuberculosis has 
been identified as the etiologic agent (Johne and Frothingham, 1895). 
Isolation of M. paratuberculosis from intestinal tissue of Crohn's 
patients, has lead to the suspicion of a potential pathogenic role for 
humans (Cocito etal., 1994; McFadden etal., 1987; McFadden etal., 
1992). 
M. paratuberculosis enters young animals from the mother's 
milk, crosses the intestinal mucosa and is phagocytized by 
macrophages in the lamina propria (Momotani etal., 1988). The 
acid-fast organism is resistant to the antimicrobial activity of the 
macrophages and, in fact, may utilize its intracellular environment 
for nutrients (Merkal, 1984). Paratuberculosis involves an 
impairment of the function of the intestinal passages, which produce 
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the main symptoms of diarrhea and weight loss. The disease 
progresses through three clinical stages (Cocito eta/., 1994). In 
stages one and two, the animal has no signs of disease and is 
catagorized as subclinical. The detectable excretion of organisms 
defines the second stage from the first. In the third stage, the animal 
is both clinical and excretory. The dominant late signs are 
emaciation, decreased milk production, loss of appetite, diffuse 
edema and anemia. The economic impact is felt when infected cattle 
do not reach market weight and when milk production is low, both of 
which are directly attributable to disease symtoms. The organism 
has been found to multiply within the intestinal tract, and produces 
an aggrevated inflammatory reaction (massive migration of 
neutrophils, macrophages, giant cells, etc.) that has been implicated 
as the cause of the lack of nutrient absorption. The fact that the 
organism displays a restricted affinity for the intestinal tract is in 
contrast to other pathogenic mycobacteria that have affinity for lung 
tissue (i. e. M. tuberculosis) or nerve tissue (i. e. M. leprae). In 
general, mycobacterial pathogens induce chronic disease that evolves 
over a period of years, with pathological damage resulting from 
detrimental activation of the host immune system rather than from 
release of potent toxins by the bacteria. Therefore mycobacterial 
virulence is related more to their ability to persist in tissues and to 
activate the immune system rather than the direct damage of host 
cells. Resistance to killing by host immune cells is, in part, a 
reflection of the structure of the mycobacterial cell wall. 
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Mycobacteria synthesize a lipid-rich cell wall which undoubtedly 
confers some degree of protection against the damaging effects of 
complement components and phagocyte-derived free radicals (Chan 
etal., 1989). 
Most of the current literature on M. paratuberculosis is 
directed at diagnostic methods that will identify the organism faster 
than culture techniques (Abbas etal., 1983; Ambrosio eta/., 1991; 
Billman etal, 1992; Hurley etal., 1989; Molina etal, 1991; Moss et 
al., 1991; Poupart etal., 1993; Thoresen and Saxegaard, 1991). As 
mentioned previously, M. paratuberculosis is an extremely slow 
growing bacterium, and, as such, identification by culture methods is 
inefficient for the purpose of diagnosis. The prolonged incubation 
time and the presence of subclinical cases, permits infected animals 
to shed large amounts of bacilli in their feces before detection. 
Moreover, current diagnostic methodology is unable to detect 
infection in the early stages of the disease (Chiodini etal., 1984; 
Cocito et al., 1994). Early detection is also hindered by the lack of 
specific DNA probes that do not cross react with related species. 
IS900 has been examined as a possible diagnostic probe (Moss etal., 
1991), but it has been found to cross react with M. avium, a closely 
related strain (Kunze etal., 1992). Idexxcoroporation has a 
commercially available IS900-based diagnostic kit that the company 
claims will identify M. paratuberculosis from infected feces. The 
complement fixation test and enzyme-linked immunosorbent assay 
tests lack both sensitivity and specificity. The fecal culture remains 
10 
the most reliable diagnostic test, but results may take up to 2 months 
due to the slow growth of the organism. In addition, animals that 
shed a low number of bacilli may give false-negative results. 
Recently, polymerase chain reaction tests have been developed to 
diagnose M paratuberculosis. Vary etal, (1990) used a DNA 
sequence from IS 900, which is present in multiple copies in the 
genome of M. paratuberculosis, to develop a M. paratuberculosis 
specific PGR reaction for the diagnosis of Johne's disease. With this 
assay, detection of 100 bacilli/ml of feces was demonstrated. 
Few M. paratuberculosis virulence determinants have been 
studied. Lipoarabinoman (Sugden etal, 1991) and glycopeptidolipid 
(Camphausen et al., 1985) are major immunogens, but their function 
in pathogenesis remains unclear. 
Procaryotic promoter biology 
Gene expression in bacteria is regulated primarily at the level 
of transcription. Transcription and its regulation have been studied 
extensively in several gram-negative bacteria, especially E. coli, but 
mostly neglected in gram-positive (with the exception of Bacillus 
subtilis) and acid-fast bacteria. The first step in transcription is the 
binding of RNA polymerase to a DNA sequence. This sequence is 
termed a promoter region. The events which must occur at a 
promoter site to initiate transcription include the attachment of RNA 
polymerase in the correct orientation and locally separating the DNA 
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strands to expose the bases to be transcribed. The sigma (a) subunit 
of RNA polymerase is involved in the recognition of a promoter 
region, which has been elegantly illustrated in Bacillus subtilis 
(Losick and Pero, 1981) by substitution of four different a factors 
during sporulation. Additionally, some lytic phages encode new a 
subunits for the host RNA polymerase, which act to program 
transcription of phage-specific genes (Talkington and Pero, 1979). 
Two regions in most a factors in bacteria probably determine the 
specificity of promoter utilization by making sequence specific 
contacts at two regions of promoters located approximately 10 and 
35 bp upstream from the start point of transcription (Rezinkoff etal., 
1985). The promoter that is recognized by RNA polymerase when 
the enzyme is combined with one specific a factor (a 70), is 
considered the typical consensus prokaryotic promoter (Reznikoff et 
al., 1985). Environmental changes or other circumstances may lead 
to a replacement of a 70 by other a factors. When this occurs, the 
promoter specificity of the RNA polymerase is altered so that a 
different group of genes is expressed. For example, under conditions 
of heat stress, the alternative a factor is a 32 in E coli (Reznikoff et 
al, 1985). In Pseudomonas aeruginosa, a 54-dependent promoters 
contain a conserved GG-Nio-GC motif (Savioz et al., 1993) which is far 
removed from the typical hexameric sequences recognized by a 70. 
Strong or weak promoters are classified as such based on the 
frequency of transcription initiation where the higher the frequency, 
the stronger the promoter. The frequency of transcription initiation 
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in E. coli can vary from genes which are transcribed less than once 
per generation to genes that are transcribed once every other second 
(McClure, 1985). Studies on E. coli promoters have suggested that 
the following factors can affect the strength of a promoter: (1) 
nucleotide sequence of the -35 region, (2) nucleotide sequence of the 
-10 region, (3) spacing between the -35 and -10 regions, (4) 
nucleotide sequence in the flanking region upstream from the -35 
region (Rosenberg and Court, 1979). Factors (1), (2), and (3) will be 
analyzed in detail throughout the present study on M. 
paratuberculosis promoter elements. Concerning factor (4), some 
powerful E. coli promoters such as the X phage pi are preceded by 
adenine and thymine (A+T) rich blocks (Horn and Wells, 1981a). 
Evidence has been presented that the upstream A+T-rich region is 
responsible for the strong promoter activity in the X pi promoter 
(Horn and Wells, 1981b). The -35 and -10 regions are descriptively 
named with respect to their location from the transcription initiation 
site and have been compiled and characterized in detail in over 160 
E. coli promoters (Hawley and McClure, 1983). Based on sequence 
homologies among 112 well-defined promoters, a very solid 
consensus promoter sequence could be established. This is only one 
of many studies (O'Neill, 1989; O'Neill and Chiafari, 1989) that qualify 
the E. coli promoter to be the most extensive and best studied single 
class of DNA regulatory sequence. Mutations that increase 
transcription initiation frequencies generally convert a nonconsensus 
base pair within a promoter to the consensus base pair for that 
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position. The reverse is true for those mutations where transcription 
initiation frequencies are decreased. The presence or absence of 
accessory factors such as cAMP-CAP or repressor molecules can also 
affect the efficiency of a promoter by several hundred fold 
(Reznikoff et a/., 1985). If promoter strength can be determined by 
how closely a sequence matches the consensus sequence, it should be 
possible to predict the strength of a promoter by its DNA sequence 
alone. Such an analysis was performed by Mulligan et al. (1984). 
They established homology scores which measured the match of 
promoters to the consensus sequence and obtained promoter 
strength values in vitro. A similar study was performed by Staden 
(1984) who took advantage of the established E. coii consensus 
promoter sequence to calculate weighted matrices that enabled 
identification of-35 and -10 regions without experimentally 
determining the transcription start site. 
Finally, it is interesting to note that although over 160 E. coli 
promoters have been sequenced, no two promoter regions with the 
identical sequence have been observed, and most promoters do not 
contain the perfect consensus -10 and -35 sequences. In fact it is 
quite rare to find a perfect consensus sequence for any a subunit. 
14 
Gene expression in mycobacteria 
Most of the studies on cloning and expression of mycobacterial 
genes have been done in E. coli. Caution must be used when 
evaluating such studies however. This is because of the belief that 
organisms such as mycobacteria with a high guanine plus cytosine 
(G+C) content in their genomes must use a very different 
transcriptional control system from that in E. coli. This effect could 
no doubt be extended to translational signals as well, especially 
considering the potential for gene regulation by codon usage (Saier, 
1995). This view is supported by the fciilure of the M. tuberculosis 
85A antigen promoter to direct transcription of the alkaline 
phosphatase reporter gene in E. coli (Kremer, etal., 1995). Other 
studies have yielded similar results (Das Gupta etal, 1993). 
However, the inherent obstacles in expression of mycobacterial genes 
in E. coli is not absolute. Thole etal., (1985) analyzed a gene library 
of M. bovis BCG in the lambda vector EMBL3 and found that 
expression of selected antigens was weak but detectable by Western 
blotting. Also, as discussed below, a mycobacterial heat shock 
promoter functions in E. coli (Thole etal., 1987). This evidence 
suggests that at least some mycobacterial genes can be expressed in 
E. coli, but probably less efficiently than in their native host. This led 
to a search for an alternative cloning host that was more closely 
related to the mycobacteria. Streptomyces species emerged as a 
possible candidate since the DNA of these bacteria also has a high G+C 
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content. When a comparitive study between E. coli and 5. lividans as 
cloning hosts was performed, it was concluded that Streptomyces is 
preferred over E. coli to clone mycobacterial expression signals 
(Kieser etal, 1986), Only recently, has it become possible to study 
gene expression or promoter biology directly in mycobacteria. Host-
vector systems have been developed that allow study of 
transcriptional activity in M. smegmatis and M. bovis BCG (Barletta et 
al, 1992). The fast-growing M. smegmatis species has rapidly 
become the genetic "workhorse" for research in this genus with the 
development of efficiently transformable strains (Snapper et ah, 
1990). As mentioned previously, E. coli promoters are probably the 
best characterized class of DNA regulatory sequence. Promoter 
biology in Bacillus subtilis has also been well characterized by the 
laboratories of Losick and Moran (Kenney and Moran, 1991; Kroos et 
al., 1989; Rather etal., 1986; Moran, 1989; Satola etal., 1991;). 
Considerably less is known, however, about promoters of species in 
the genus Mycobacterium. Complex studies of gene expression such 
as global regulation, a factor switching, and positive and negative 
regulation are all well established in E. coli and B. subtilis but are not 
yet possible in mycobacteria. 
Despite their highly pathogenic nature and importance as 
heterologous expression systems (Barletta etal., 1990; Dellagostin et 
al., 1993; Stover etal., 1991; Stover etal., 1993), gene expression in 
mycobacteria is poorly understood because of the great difficulties 
encountered when working with these organisms. As recently as 
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1991, no intact mRNA had been successfully extracted from 
mycobacteria due to the short half-life of prokaryotic mRNA and the 
difficulty in achieving rapid lysis (Patel etal., 1991; Bashyam and 
Tyagi, 1994). This inability to extract RNA from mycobacteria forced 
investigators to perform very limited characterization of 
transcriptionally active mycobacterial cloned fragments in a 
heterologous host. Those investigators that did perform more 
detailed studies such as transcription start site experiments, used E. 
coli RNA when analyzing mycobacterial promoters (Sela and Clark-
Curtiss, 1991). Another contributing factor for the lack of knowledge 
regarding mycobacterial promoter biology is that the a factor of RNA 
polymerase has not yet been identified or studied in this system. 
However some advancements in the field of mycobacterial genetics 
have been made, especially recently. Several enzymatic and 
mechanical methods for DNA extraction have been reported (Hill et 
al, 1972; Patel etal., 1986; Whipple etal., 1987) and have led to the 
establishment of gene libraries for Mycobacterium leprae (Clark-
Curtiss etal., 1985) and M. tuberculosis (Young etal., 1985; Cole and 
Smith, 1994). The subsequent development of suitable hosts and 
vector systems for working with mycobacteria (Jacobs etal., 1991; 
Snapper etal., 1990; Hinshelwood and Stoker, 1992; Qin etal., 1994) 
meant that many of the difficulties encountered while working 
directly with pathogenic mycobacteria could be alleviated. Shuttle 
cosmids have been constructed that contain an origin of replication 
that functions in E. coli, an origin of replication that functions in 
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mycobacteria, a kanamycin-resistance gene that functions in both E. 
coli and mycobacteria, bacteriophage X cos sequence that permits 
these molecules to be packaged into bacteriophage X heads, and 
unique restriction sites for construction of genomic libraries (Jacobs 
etal., 1991). A rudimentary transposon mutagenesis system has 
been developed (Martin etaL, 1990; McAdam etal., 1994). 
Moreover, promoter-probe shuttle vectors have been engineered 
which can replicate between E. coli and M. smegmatis (Barletta et al, 
1992; Das Gupta etal., 1993). Yet, despite these recent 
advancements, little is known about mycobacterial gene promoters 
and their activities. There has been some evidence suggesting that 
mycobacterial promoters are distantly related to promoters of other 
microorganisms (Sirakova etal., 1989; Das Gupta etal., 1993). A 
mycobacteriophage (L5) as been discovered and sequenced and may 
become an important tool in mycobacterial genetics (Lee and Hatfull, 
1993; Hatfull, 1995). The most extensively studied mycobacterial 
promoter is that which controls expression of the heat shock protein 
genes (Thole etal., 1987; Stover etal., 1991). Those promoters 
controlling the expression of heat shock proteins are among the rare 
ones that have been shown to be active in E. coli (Thole et al., 1987). 
Therefore, heat-shock promoters, which are functional in both 
mycobacteria and E. coli, should be useful in controlling expression of 
recombinant genes in E. coii-mycobacteria shuttle vectors. More 
recently, other mycobacterial promoters isolated from M. 
paratuberculosis (Thomas etal., 1992; Murray etal., 1992) and M. 
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fortuitum (Timm etaL, 1994) were found to contain well-conserved 
-10 and -35 regions. Caution must be used when evaluating these 
studies since these sequences were all active in E. coli and therefore 
may not be representative of true mycobactericd promoter 
structures. 
Recombinant Mycobacterium bovis BCG as a vaccine 
An important application in the study of mycobacterial 
expression signals is to enable expression of foreign antigens in the 
attenuated M. bovis BCG (Bacille Calmette-Guerin) strain. Since 
mycobacteria are excellent adjuvents for humoral response as well as 
powerful mediators of cellular immunity (Aldovini and Young, 1991), 
the expression of foreign antigens in BCG would allow the 
construction of recombinant vaccine strains against human diseases 
of bacterial, viral, and parasitic etiology. M. bovis BCG was derived in 
1906 from a virulent bovine strain by passage with ox bile for 231 
passages (Calmette etai., 1933). BCG is now the most widely used 
vaccine in the world against tuberculosis (Fine, 1988), although it is 
currently not used in the United States because of efficacy issues 
(Christensen, 1993; Bloom and Fine, 1994) and vaccinated persons 
would exhibit a positive reaction with the tuberculin skin test (Bloom 
and Fine, 1994). In other countries, the low frequency of serious 
complications and inexpensive production msike BCG an ideal 
candidate for a recombinant vaccine vehicle. Since BCG, particularly 
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its cell wall, is a highly effective adjuvant, conjugation of an antigen 
to an adjuvant would be unnecessary when using recombinant BCG. 
In order to obtain a high level of foreign antigen expression in BCG, it 
is essential have strong mycobacterial expression signals. Currently 
there exists a multicopy plasmid and an integative expression vector, 
both of which carry the regulatory sequences for major BCG heat 
shock proteins to allow expression of foreign antigens (Stover ef al., 
1991). However, even under the control of the same promoter, the 
amount of protein expressed in this system varies from 10% to less 
than 0.1% of the total protein extracted (Murray etal., 1992). There 
is also variable expression of heterologous antigens among several M. 
bovisBCG strains (Burlein etal, 1994), With the cloning of 
additional mycobacterial gene expression signals, it may be possible 
to find promoters that are stronger and drive expression at more 
consistent levels than the heat shock promoters currently in use. 
Three different human immunodeficiency virus type 1 (HIV-1) 
polypeptides have been expressed in BCG under the control of the 
mycobacterial hsp70 promoter (Aldovini and Young, 1991) and 
shown to elicit antibody and T cell responses. BCG also offers 
potential advantages as a vector for mucosal delivery of antigens. A 
single intranasal vaccination with recombinant BCG expressing the 
outer-surface protein A antigen from Borrelia burgdorferi, the 
etiological agent of lyme disease, results in a prolonged protective 
IgG response and a sustained secretory IgA response which is 
disseminated throughout the mucosal immune system (Stover et al., 
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1993; Langermann etai., 1994). The protective effects of 
recombinant BCG will undoubtedly be established for several 
pathogens in the future. It may even be further extended to allow 
simultaneous expression of multiple protective antigens of different 
pathogens, all in one vaccine. 
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CHAPTER 2. IMPROVEMENT OF THE PROMOTER-PROBE 
VECTOR pKOl FOR CLONING TRANSCRIPTION SIGNALS 
FROM Mycobacterium paratuberculosis. 
A paper to be submitted to the Journal Gene 
John P. Bannantine, C. 0. Thoen, and R. E. Andrews, Jr. 
ABSTRACT 
The promoter selection vector pKOl has been modified to include the 
unique cloning sites BaihHl, Sad, Kpnl, Aval, Xbal, and Psd. The 
new vectors (pjjl and pJJ2) allow the transcriptional fusion of genes 
to galactokinase (galK) in all three translational reading frames. 
Insertion of M paratuberculosis DNA fragments upstream of galK 
into the unique BamHl site of pJJ2 results in expression of galK. This 
newly constructed vector has been used to show that a previously 
sequenced M. paratuberculosis promoter-containing fragment 
(Thomas et al., 1992) and 11 novel M. paratuberculosis promoter-
containing fragments produced galK activity in E. coli. One of the 11 
promoters (pTB28), which displayed high levels of galK activity on 
MacConkey's medium, was sequenced. Potential -35 and -10 
promoter regions were identified from this sequence. SI nuclease 
digestion of the 493 bp promoter-containing fragment from Thomas 
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et al. was used to determine the transcription start site in E. coli. The 
start point was 124 nucleotides upstream from the putative initiation 
codon and the -35 and -10 regions resembled the E. coli consensus 
promoter. The 493 bp fragment was also subcloned into the 
promoter-probe shuttle vector pYUB75 and designated pAJB60. 
When pAJB60 was transformed into both E. coli and M. smegmatis 
hosts, the lacZ reporter gene was expressed only in the mycobacterial 
host. 
INTRODUCTION 
A number of plasmid vectors have been constructed for the 
purpose of cloning and the subsequent evaluation of DNA fragments 
with promoter activity (McKenney etal., 1981; Bagdasarian etal, 
1983; Barletta etal., 1992; Timm etal., 1994). Such promoter-probe 
vectors rely on the in-phase fusion of the promoter-containing DNA 
to a structural gene or a selectable marker. The plasmid pKOl is a 
commonly used promoter-probe vector for E. coli (McKenney et al., 
1981; Sirakova etal., 1989). In this vector, the E. coli galactokinase 
gene (galK) provides the assayable marker to which transcriptional 
regulatory signals are fused. The promoterless galK reporter gene 
has been used successfully to detect mycobacterial promoter 
elements in a heterologous environment (Sirakova etal., 1989; 
Thomas etal., 1992). The limitations of pKOl as a promoter selection 
vector include the lack of unique restriction sites upstream of galK 
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for the cloning of transcriptionally active DNA fragments and the 
distance of the cloning sites relative to the start of the galK reporter 
gene. The location of the restriction sites in pKOl is not immediately 
upstream of galK which forces a cloned promoter to transcribe 
additional unnecessary plasmid sequences prior to reaching the 
reporter gene. For these reasons, pKOl was also modified by 
removing the unnecessary vector sequences without disrupting or 
deleting the translational stops upstream of galK. 
The genus Mycobacterium includes major pathogens such as 
Mycobacterium tuberculosis and M. leprae, the etiological agents of 
tuberculosis and leprosy. M. avium and M. paratuberculosis are 
closely related intracellular pathogens affecting humans and animals. 
The avirulent strain of M. bovis that has been extensively used as a 
tuberculosis vaccine, is also an attractive vector for the construction 
of live recombinant vaccines because of its strong immunogenicity. 
As a result, there is currently much interest in studying the 
molecular biology of mycobacteria. 
Gene expression in mycobacteria, particularly Mycobacterium 
paratuberculosis is ill-defined. This can be attributed to a variety of 
factors including their slow growth rates, lack of genetic exchange 
methods such as transduction or conjugation, and inability to 
construct, detect and assay for mutations. The cloning and analysis 
of mycobacterial gene expression signals may provide clues to its 
pathogenic mechanisms as well as improve upon a system to drive 
expression of foreign antigens in M. bovis BCG. 
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In the present study, we describe the construction of pjjl and 
pJJ2 promoter selection vectors, which have the advantage of 
convenient multiple cloning sites as well as allowing transcriptional 
fusions to galK. The utility of the vectors for producing 
transcriptional fusions was shown by cloning and assessing gene 
regulatory sequences from both a previously characterized M 
paratuberculosis promoter (Thomas etal., 1992) and an M. 
paratuberculosis genomic DNA library. 
MATERIALS AND METHODS 
Bacterial strains and plasmids. M. paratuberculosis ATCC 
19698 was provided by D. Whipple NADC, Ames, lA and served as 
the source from which genomic DNA was isolated. E. coll HBlOl 
{galK, recA), E. coll RRl igaK), and E. coll TG-1 (F+) were used for 
cloning M. paratuberculosis promoters and production of single-
stranded DNA, respectively. The promoter-probe plasmid pKOl 
(Thomas etal., 1992) was a laboratory stock. Helper phage R408 for 
production of single-stranded DNA templates was obtained from F. C. 
Minion, Department of Microbiology, Immunology, and Preventive 
Medicine (MIPM), Iowa State University, Ames, lA. Plasmid pKRBS 
was provided by G. Phillips, Department of MIPM. The shuttle 
vectors pYUB75 and pYUB76 (Barletta etal., 1992) and M. smegmatis 
mc2l55 were provided by R. Barletta, Department of Veterinary 
Science, University of Nebraska, Lincoln, NE. Plasmids pYUB75 and 
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pYUB76 have a kanamycin resistance marker for selection, contain a 
promoterless lacZ gene, and replicates in both £ coli and M 
smegmatis. 
Growth conditions and extraction of M. 
paratuberculosis DNA. For genomic DNA isolation, M, 
paratuberculosis was incubated without shaking in Middlebrook 7H9 
broth (Difco, Detriot, MI) containing 0.5% Tween-80, OADC 
enrichment (Difco) and 2 mg/1 mycobactin J (Allied Monitor, Fayette, 
MO). The cells were harvested after 5 weeks of growth in tissue 
culture flasks at 37oC. M. paratuberculosis pellets (1 to 3 g) were 
frozen at -70oC and genomic DNA was extracted by the method of 
Whipple etal. (1987). 
Construction of Plasmid pjjl and pJJ2. To create pjjl 
and pJJ2, the poly linker along with the spectinomycin/streptomycin 
resistance cassette was excised from pKRBS by digestion with EcoRl 
and cloned into the EcoBl site of pKOl (Figure 1). The resulting 
construct, designated pK08, was then digested with Hindlll and 
allowed to self-ligate to remove half of the symmetrical polylinker, 
pKOl sequences 5' to the galK gene, and the spectinomycin/ 
streptomycin cassette. This new construct was designated pJJ2. The 
pjjl construct was created by digestion of pK08 with BamHl followed 
by vector religation. Only the spectinomycin/ streptomycin cassette 
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and a portion of the multiple cloning site were removed by this 
treatment. 
Cloning of JVf. paratuberculosis promoters in pJJ2. 
Genomic DNA from M. paratuberculosis was partially digested with 
5au3AI and fractionated by agarose gel electrophoresis. Fragments 
of this digestion in the 100 to 1000 bp range were purified by 
electroelution from an agarose gel. A ligation reaction was prepared 
by mixing approximately 0.5 |ig of purified genomic DNA fragments 
with 1 |xg of dephosphorylated, BamHI-cleaved pJJ2 in a final volume 
of 10 |il. Half of the ligation mixture was used to transform E. coli 
RRl using a highly efficient CaClz method (Miller, 1992). The 
transformed cells were plated on MacConkey's containing 1% 
galactose and Ampicillin (Apr, 100 ij.g/ml). 
The 493 bp £coRl promoter-containing fragment from pAG5 
(Thomas etal., 1992) was gel purified and cloned into the £coRl site 
of p34E (Tsang etal, 1991). The fragment was removed from p34E 
by digestion with BamUl and cloned into the BamHl site of pYUB75 
(Barletta et al., 1992) where lacZ serves as the reporter gene. The 
ligation mixture was transformed by electroporation into £ coli 
DHIOB and plated on Luria-Bertani (LB) medium containing 50 
|ig/ml kanamycin. The LB medium also contained 5-bromo-4-
chloro-3-indolyl-p-D galactopyranoside (Xgal) added to each plate as 
described by Sambrook etal, (1989). Kanamycin resistant colonies 
obtained from this experiment were screened by plasmid extraction 
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(Qiagen, Inc., Chatsworth, CA) and restriction analysis for 
confirmation of the construct which was given the designation 
pAJB60. This construct was then electroporated into M. smegmatis 
mc2l55 to assess p-galactosidase expression in that background. The 
selective media for M. smegmatis electroporations was Middlebrook 
7H9 medium (Difco, Detriot, MI) with 50 jig/ml kanamycin and Xgal 
added as described above. 
Estimation of promoter strength by p-galactosidase 
assays. The p-galactosidase assays for E. coli were performed as 
described by Miller (1972) with one modification. The minimal 
medium for growth recommended by Miller was not employed due 
to poor growth of E. coli DHIOB. Instead, LB medium was substitued 
for minimal medium, p-galactosidase assays for M. smegmatis'were 
performed as described by Barletta eta7., (1992). p-galactosidase 
activities were reported in Miller units (Miller, 1972). 
RNA extraction. Total cell RNA was isolated from E. coli by 
routine methods (Ausubel etal., 1989). 
DNA sequencing. Sequencing reactions were performed 
manually with Sequenase® Version 2.0 sequencing kit (United States 
Biochemical Corporation, Cleveland, OH) for generating molecular 
weight markers with phage Ml3 as the DNA template to resolve the 
size of the SI mapped product. 
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The galK positive clone with the smallest insert, pTB28, was 
subcloned into pGEM3Zf(+) (Promega, Madison, WI) for DNA 
sequencing. The promoter-containing insert was isolated from 
pTB28 by a Hindlll-EcdRl double digestion. The vector pGEM3Zf(+) 
was digested in a similar manner and included in a ligation reaction 
that also contained the pTB28 fragment. The resulting construct was 
designated pSEQ4. 
The pSEQ4 insert was sequenced by using the Tag DyeDeoxy® 
Terminator Cycle Sequencing Kit (Perkin Elmer/Applied Biosystems 
Division, Foster City, CA). The sequencing primers included the 
universal forward and reverse Ml3 primers that were 
complementary to regions flanking the multiple cloning sites on 
pGEM3Zf(+). Each sequencing reaction included 100 ng of template 
DNA and 10 pmol of sequencing primer in a total volume of 20 jxl. 
Each reaction underwent 25 cycles (98oC for 15 s, 50oC for 10 s, 60oC 
for 4 min) in the GeneAmp PGR System 9600 thermal cycler (Perkin-
Elmer, Norwalk, Conn.). The sequencing products were purified 
through Centri-Sep columns (Princeton Separations, Adelphia, N.J.) 
and were loaded onto 6% denaturing polyacrylamide gels in an 
automated sequencer (373A DNA Sequencer; Perkin elmer/Applied 
Biosystems Division). Template DNA for automated sequencing was 
prepared by one of two methods; PEG prepsiration (Tartof and Hobbs, 
1987) or Qiagen extraction. The Qiagen miniprep was performed 
according to the instructions of the manufacturer (Qiagen). 
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SI-nuclease mapping. The 493 bp EcoRl fragment from 
pAG5 was isolated from a 0.8% low melting agarose gel. The 5' 
hydroxyl  end was radiolabeled wi th  [ t -^zpjatp (3000 mCi mmole - i ,  
Amersham) using polynucleotide kinase (lOU). Unincorporated 
radioactivity was removed by two consecutive ethanol precipitations. 
E. coli RNA (30 jxg) and radiolabeled DNA probe (0.5 |ig) were mixed 
and precipitated with ethanol and 3M sodium acetate. The pellet 
was resuspended in 45 |il of hybridization buffer (40mM piperazine-
N-N'-bis-ethanesulphonic acid (PIPES), ImM EDTA (pH 8.0), 0.4M 
NaCl, 80% formamide) and incubated at 62oC for 12 h. DNA/RNA 
hybrids were subjected to Sl-nuclease (300U) digestion at 37oC for 
l-2h. The reactions were terminated by the addition of 80 |il of Sl-
nuclease stop buffer (4M ammonium acetate, 50mM EDTA (pH 8.0), 
50 |ig/ml tRNA). Reactions were heat denatured at 90oC for 2 min. 
then separated on a 6% denaturing polyacrylamide gel (Sambrook et 
al., 1989). 
RESULTS 
Construction of pjjl and pJJ2. pjjl and pJJ2 are 
transcriptional fusion vectors where promoter fragments are cloned 
upstream of the galK ribsomal binding site (RBS) and translational 
stop codons in all three reading frames. Figure 1 shows the general 
cloning strategy used to construct these vectors and Figure 2 shows 
the deduced nucleotide sequence comparison of pKOl, pjjl, and pJJ2 
Figure 1. Construction of plasmids pjjl and pJJ2. The 2.8-kb Eco RI fragment of pKRB8 was 
cloned into the fcoRI site of pKOl. The resulting plasmid, pKOS, was digested with 
either BaniHl (pjjl) or Hind III (pJJ2) and self-ligated to remove the 
spectinomycin/streptomycin resistance cassette. 
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Plasmid pKOl: 
fcoRI 
GMEICTGGC GAATCCTCTG ACCAGCCAGA AAACGACCIT TCTGTGGTGA AACCGGATGC TGCAATTCAG AGCGCCAGCA 
AGTGGGGGAC AGCAGAAGGA CCTGACCGCC GCAGAGTGGA TGTTTGACAT GGTGAAGACT ATCGCACCAT CAGCCAGAAA 
fcoRV 
ACCGAATTTT GCTGGGTGGG CTAACGATAT CCGGCTGATG CGTGAACGTG ACGGACGTAA CCACCGCGAC ATGTGTGTGC 
Spbl Hindlll Smal 
TGTTCCGCTG GGTATGCCAG GACAACTTCT GGTCCGGTAA CGTGCTGAGC CCGGCCMGCTrACTCCCCA TCCCCGGGTA 
ATAAGGGCTG CACGCGCACT TTTATCCGCC TCTGCTGCGC TCCGCCACCG TACGTAAATT TATGGTTGGT TATGAAATGC 
TGGCAGAGAC CCAGCGAGAC CTGACCGCAG AACAGGCAGC AGAGCGTTTG CGCGCAGTCA GCGATATCCA TTTTCGCGAA 
TCCGGAGTGT AAGAAATG <- galK start 
Plasmid pjjl: 
^coRI 5acl Kpnl BamEl Kpnl Sad EcoRI 
GAATTCGAGC. TCGGTACCCG GGGATC.C.CCG GGTACCGAGC. TCGAATTCTG GCGAATCCTC TGACCAGCCA GAAAACGACC 
TTTCTGTGGT GAAACCGGAT GCTGCAATTC AGAGCGCCAG CAAGTGGGGG ACAGCAGAAG GAGCTGACCG CCGCAGAGTG 
EcoRV 
GATGTTTGAC ATGGTGAAGA CTATCGCACC ATCAGCCAGA AAACCGAATT TTGCTGGGTG GGCTAACGAT ATCCGCCTGA 
SphI 
TGCGTGAACG TGACGGACGT AACCACCGCG ACATGTGTGT GCTGTTCCGC TGGGCATCCC AGGACAACTT CTGGTCCGGT 
HJndlll Smal 
AACGTGCTGA GCCCGGCCAAGC TTACTCCCCA TCC££GffiCA ATAAGGGCTG CACGCGCACT TTTATCCGCC TCTGCTGCGC 
TCCGCCACCG TACGTAAATT TATGGTTGGT TATGAAATGC TGGCAGAGAC CCAGCGAGAC CTGACCGCAG AACAGGCAGC 
AGAGCGTTTG CGCGCAGTCA GCGATATCCA TTTTCGCGAA TCCGGAGTGT AAGAAATG <- galK start 
Plasmid pJJ2: 
EcoBl Sad Kpnl BamEl Xbal Pstl Spbl HindlU Smal 
GAATTCGAGC TCGGTArCCG GGGATCCTCT AGAGTCGACG TGGAGGGATG CAAGCTTACT CCCCATCCCC C/^ tCAATAAG 
GGCTGCACGC GCACITTTAT CCGCCTCTGC TGCGCTCCGC CACCGTACGT AAATTTATGG TTGGTTATGA 
AATGCTGGCA GAGACCCAGC GAGACCTGAC CGCAGAACAG GCAGCAGAGC GTTTGCGCGC AGTCAGCGAT 
ATCCATTTTC GCGAATCCGG AGTGTAAGAA ATG <- gal K start 
Figure 2. Deduced nucleotide sequence comparison of the regions upstream of galK in pKOl, 
pjjl, and pJJ2. Restriction sites are indicated by an underlined recognition 
sequence with the restriction enzyme designation above it. The galK translational 
start is indicated and the upstream translational stops are shown in bold. 
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immediately 5' to the galK gene. The translational stops from the 
pKOl parent were preserved in pjjl and pJJ2 (Figure 2). Figure 3 
shows the restriction patterns of the described plasmids that verifies 
their construction. The plasmid-encoded antibiotic ampicillin serves 
as the selectable marker, whereas the red-white colony color on 
MacConkey's allows for quick identification of promoter-containing 
inserts based on acid byproducts from galactose utilization. £ coli 
cells harboring pjjl or pJJ2 showed no detectable galK activity on 
MacConkey medium. 
Cloning of the pAG5 insert and M. paratuberculosis 
5au3AI fragments into pJJ2. In order to clone mycobacterial 
promoters, ligations and transformations were carried out as 
mentioned in Materials and Methods. The ligation reaction yielded a 
1,553 clone library of which 11 were galK positive. The frequency of 
promoter isolation was expressed as a percent with the number of 
red colonies (promoter-containing clones) divided by the number of 
white colonies. Thus 0.7% of this non-representative library contains 
putative promoter clones. Three galK positive clones (pTB12, pTB22 
and pTB28) contained strong promoters as determined by intensity 
of red color and were found to contain insert sizes of 1400, 720, and 
600 bp respectively. The smallest clone (pTB28) was subcloned into 
pGEM3Zf(+) and sequenced. 
Previously, a M. paratuberculosis DNA library was cloned into 
pKOl (Thomas etal., 1992). One galactokinase positive clone from 
Figure 3. Restriction analysis and agarose gel electrophoresis of pjjl, 
pJJ2, cind intermediate constructs pKOl, pK08, and pKRB8. 
Shown is a 0.8% agarose gel containing the following lane 
assignments: lane 1, fcoRI-digested pKRB8; lane 2, 
Hiiidlll-digested pKRB8; lane 3, BamUl-digested pK08; 
lane 4, EamHI-digested pjjl; lane 5, Hiudlll-digested 
pK08; lane 9, ^ aiJiHI-digested pJJ2. 
1  2 3  4 5  6 7  8 9  
0.8% Agarose gel 
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this library (pAG5) contains a 493 bp EcoRl fragment which was 
subcloned into pJJ2 to give pTBlO and used to test the efficacy of the 
newly constructed vector. Both pTBlO and pAG5 display similar 
levels of galK activity as determined by intensity of red color on 
MacConkey's plates (data not shown). These data show that 
modifications of pKOl to construct pJJ2 did not alter the galK 
reporter activities. 
Subcloning of the pAG5 insert into pYUB75 and 
expression of lacZ in M. smegmatis. It has been shown 
previously that the 493 bp M. paratuberculosis insert of clone pAG5 
acts as a promoter element in E. coli (Thomas etal., 1992). To 
establish that the 493 bp DNA fragment contains legitimate 
mycobacterial promoter sequences, the fragment must drive 
expression of a reporter gene in a mycobacterial host. To accomplish 
this objective, the insert of pAG5 was subcloned into pYUB75, a 
promoter selection vector that replicates in M. smegmatis. This 
subclone, designated pAJB60, was transformed by electroporation 
into both the E. coli and M smegmatis backgrounds where expression 
of the lacZ reporter gene was assessed quantitatively (Table 1). E. 
coli (pUC19) was used as a positive control with M. smegmatis and E. 
coli harboring pYUB75 serving as negative controls. Interestingly, a 
lacZ fusion was not produced in E. coli, but was in M. smegmatis since 
p-galactosidase was shown to be expressed in M. smegmatis, but was 
not detectable in E. coli (Table 1). Nucleotide sequencing of pAJBGO 
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(Bannantine et al., in preparation) has revealed that the 493 bp M. 
paratuberculosis fragment was cloned in the opposite orientation 
relative to pTBlO or pAG5 (Thomas etal., 1992). 
Table 1. Measurement of promoter activity from the 493 bp M. 
paratuberculosis DNA fragment. 
Strain Colony color^ p-galactosidase 
activity^ 
E. coil DHIOB (pUC19) Blue 91±8.4 
E. coii DHIOB (pYUB75) White 0.35±0.071 
M. smegmatis (pYUB75) White 0.26±0.058 
E coii DHIOB (PAJB60) White 0.35±0.083 
M. smegmatis (pAJB60) Blue 1.9±0.29 
a Colony color was scored on Xgal containing medium. 
Reported figures are in Miller Units (Miller, 1972) and are the 
average from three independent trials + standard dev. 
Nucleotide Sequencing of the pSEQ4 insert. The pSEQ4 
insert is 518 bp long and has a G+C content of 64.1%, which is slightly 
lower than the published figure of 66-67% for M. paratuberculosis 
(McFadden etal., 1987). To locate possible promoter sites, the 
sequence was examined for mycobacterial consensus regions that 
have been recently established (Bannantine etai., in preparation). 
The 518 bp sequence is shown in Figure 4 along with the potential 
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GATCTCCAGCGGCGCGGTGACCACCAGACAGGCGGCGAGCACCACCAGGTATTGCCACCGAT 
CCGCCAAGAGCGCAGTACCCCCACGCTCACGGGCGGCGTrGAAATAGGTAGTAATACGTCGG 
GGTCrrGTCGTCGAGCGCCCGCTCCTGGCCAGTGGACAACAGCGTCCAACCCGCGGTGAACCG 
CCGTrCGATrrCGGCGCGATCGGCATCGACGCCACACCCATCGAGCGGGCGTCCAACACGCTG 
ATCATCATCTrCGGCrCGAAGCGGACCnTACAGCCTCAGTCATATCTGTCACTCTdTCTGGG 
TCGCGGAGGGGCrACGGAGAGCCTTACCGGAAACTAGCGGATTGGCAAGCTGCGGCCGCCGC 
CGGGCTGGTTATTGCGGGTCGAACAGCACCGGGACCGACGTCGGCGACCGGAACACCTGGC 
-35 -10 
"kick 
CCCGGATGTGGGGATCGAGGAAGTCATCGCGSTQAACCCCAAGGTGTTCTTCCAGGTGTAC 
RBS 
TGGCTGGGTGGGCGCGACGG 
Figure 4. Nucleotide sequence of the 518 bp insert of pSEQ4. Only 
mycobacterial DNA is shown, no vector sequences. The 
sequence is written 5' to 3' and in pTB28, the galK gene 
would be on the 3' end. The potential transcriptional 
signals (-35 and -10 regions) as identified by matching 
the conserved promoter regions established by 
Bannantine et al. (in preparation) and the ribosome 
binding site (RBS) are highlighted in bold letters. The 
putative start codon is underlined. The three above 
the TGA codon indicate the stop codon present in frame 3. 
-35 and -10 regions that are highlighted in bold letters and closely 
resemble conserved promoter regions in mycobacteria. Nine of 
twelve base pairs in the -35 and -10 regions are consensus 
nucleotides. These identified conserved regions combined with a 
purine-rich ribosome binding site and well-positioned initiation 
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codon provide strong evidence for the proper location of the 
promoter region. 
SI nuclease mapping. To determine the 5' end of the 
transcript from pTBlO in E coli, 20 |ig of total cell RNA from E coli 
was hybridized to 0.5 |j.g of the denatured, [y-^^pjATP labeled 493-
bp fragment. Hybridization conditions were those favoring the 
formation of DNA-RNA hybrids (Sambrook etal, 1989). The length 
of protected single-stranded DNA fragments was determined by 
comparison with Ml3 DNA sequencing ladders (Figure 5). The SI 
mapped product of 164 bp nucleotides in length, indicating a 5' 
mRNA start site 15 nucleotides downstream from the -10 region 
reported by Thomas etal. 1992 (Figure 6). 
Figure 5. SI nuclease mapping of the 493 bp pAG5 fragment in E. coli 
HBIOI. The phage Ml3 nucleotide sequence is shown in the 
lanes labeled G, A, T, and C. Lane 1, the DNA:RNA hybrid 
which was not subjected to SI nuclease digestion. Lane 2 
contains the SI nuclease digested product which has a 
length of 164 nucleotides (nt). 
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Control 
A-rsv^>.'>;i 
pIBI 
^<.. SI product 
^ "t (164 nt) 
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GAATTCGGCGACGAAATCGGTGAACGGCAGCACCAGCGCCTCGCG -280 
GAACAGCGCCGCCTTGGAACCGAAGTGGCGGAACAGCAGATGCTC -235 
GGTTACCCCTGCGGCCTGGGCGATTTCGCGTGTCGTGGTGCTTCGG -189 
TAGTCCTGCCGGGCAAAGCGGGCCCGGGCCGTGTCGAGCAGCAGC -144 
TGGCGCGGCGCGCCGCGGGGCCGGCGGATCGAGGCCGGCGCCGCTG -98 
CCGCGCCGCCGCCTGGACGGCCGCTGGGCCACGTGGTGTCCTCTCG -52 
TCGATGCpffGAC^AGGATAGTGTGCACT^TCTAATlGAGTCGAG -7 
I ^ 
CTCGGATCGGAAGGGGTGCGGCCGTGGGCGCTGTCATCATGCTCG 39 
GCACGCTGTTCGGATTGATCGTGTTGATCTTCGGGCTGGTGCTGC 84 
GCTTCGACCCGCAAGCCCGCCGGAGCCGCCAGGCTGACCG ATGAG 129 
CGCGCAGATG ACGCCGGTGATGCAGGCGGCCAGTGAATTC 169 
Figure 6. Nucleotide sequence of the 493 bp fragment with salient 
features. Shown is the nucleotide sequence of the pAG5 
insert as determined by Thomas etal. (1992) and 
confirmed in this study. The putative -35 and -10 
regions are shown in shaded boxes and the transcription 
start site, determined by SI nuclease mapping is 
indicated by an arrow over the nucleotide. The potential 
translationil start codon is underlined. 
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DISCUSSION 
The utility of pKOl as a promoter-probe selection vector is 
limited by a lack of unique restriction sites 5' to the gaK reporter 
gene. M. paratuberculosis genomic DNA is cleaved most efficiently 
with 5au3AI for generating restriction fragments in the 0.2 to 1 Kb 
range which are large enough to contain a single promoter region but 
small enough to be easily sequenced. However, SauSAl generates 
cohesive ends which are not compatible for ligation to the restriction 
sites that exist in pKOl. To overcome this limitation, several unique 
restrictions sites were added to construct the pKOl derivatives pjjl 
and pJJ2. The vector pJJ2 was tested for its ability to recognize 
transcriptionally active M. paratuberculosis fragments. Of 11 galK-
positive clones, pTB28 was selected for subcloning and sequencing 
because of its small insert size (518 bp) and strong galK activity. The 
sequenced fragment was found to contain potential mycobacterial 
consensus promoter regions. Detailed analysis of mRNA will be 
necessary in order to determine whether the consensus sequences 
indicated here do in fact correspond to the transcriptional start site. 
With regard to cloning mycobacterial promoters, a limitation of pKOl 
is that it cannot replicate in any mycobacterial host and ampicillin is 
not a selectable marker in mycobacteria (Kaneda and Yabu, 1983). 
In this investigation, a sequenced M. paratuberculosis promoter 
element (Thomas, etal, 1992) of 493 bp was subcloned into pJJ2 and 
the Escherichia-Mycobacterium shuttle vector (pYUB75) and 
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phenotypically shown to express the reporter gene in both vector 
systems. This same sequence drove expression of galaktokinase in E. 
coli, but not lacZ in E. coli. This is because the insert is in the 
opposite orientation in pAJB60 relative to pTBlO. Therefore E. coli 
recognizes the M. paratuberculosis DNA sequence as a promoter in 
one orientation and M. smegmatis recognizes it in the opposite 
orientation. SI nuclease mapping of the galK transcript produced in 
E. coli identified the location of the 5' end to be 15 bp downstream of 
the Pribnow box. This transcription start site agrees well with that 
predicted from Thomas etal. (1992) and resembles an E. coli 
consensus promoter more than a mycobacterial consensus promoter. 
From these data, it was reasoned that the 493 bp fragment contained 
a fortuitous promoter region that E. coli recognizes but is not 
biologically significant in mycobacteria. Moreover, when the 
fragment is cloned in the reverse orientation, it drives expression of 
a reporter gene in M. smegmatis and is therefore considered to be a 
legitimate mycobacterial promoter-containing fragment. Northern 
hybridization analysis of the galK transcript in E. coli was performed 
(data not shown) to show transcriptional activity in that system, 
however the identified transcript was larger than the expected size 
of 1.9 kb for the galK fusion transcript. This may be explained by a 
run on transcript where RNA polymerase transcribed through the 
terminator sequence at the end of galK. Transcriptional activity of 
pAJB60 in M. smegmatis was observed and quantitated by slot blot 
hybridization (Bannantine etal., in preparation). 
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The quantitative p-galactosidase data shows that the pAG5 
fragment does contain promoter activity in a mycobacterial host. 
One limitation of the p-galactosidase assay for mycobacteria, as 
stated by Barletta et aJ. (1992), is that toluene permeabilization may 
not work as efficiently as it does for £ coii. Therefore the data 
presented should be viewed as a relative comparison of activity and 
not as the actual number of p-galactosidase units. In light of this 
information, it is probable that M. smegmatis cells harboring the 
pAJB60::JacZ fusion produces more p-galactosidase activity than 1.9 
units. 
With the prospect of successful cloning of M. paratuberculosis 
promoters in different hosts, it may eventually become possible to 
determine which genes are expressed within the host. This could be 
accomplished by an analysis of M. paratuberculosis promoters that 
are turned on when grown in vivo and turned off when grown in 
vitro. Subsequent studies could be targeted to these promoters or 
the genes they express, and along with it, the organism's ability to 
persist within the host. 
The vector pJJ2 is a more versatile promoter-probe vector than 
pKOl since it contains additional unique restriction sites. It has the 
added advantage that unnecessary pKOl plasmid sequences between 
the cloning sites and the galK reporter gene are removed. 
Furthermore, cloning of SauSAl fragments into the BamHl site, a 
procedure known to result in imperfect BamUl sites, can still result 
in easy removal of the insert from the vector using flanking 
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restrictions sites. The evidence above casts some doubt on the utility 
of pjjl or pJJ2 for cloning mycobacterial transcription signals since 
M. paratuberculosis sequences may be fortuitously recognized as 
promoters in E. colL However, M. smegmatis cells harboring pAJB60 
are iacZ-positive which is indicative of a legitimate mycobacterial 
promoter sequence. 
The results herein show that M. paratuberculosis sequences can 
serve as promoters in E. coli and M smegmatis. While expression of 
these sequences in a mycobacterial host gives compelling evidence, 
whether these sequences are in fact legitimate promoters of M. 
paratuberculosis is the subject of future studies. 
ACKNOWLEDGEMENTS 
We thank the DNA sequencing and synthesis facility (1184 
Molecular Biology building, Iowa State University) for sequencing of 
the pSEQ4 insert. 
REFERENCES 
Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. 
Seidman,J. A. Smith, and K. Struhl. 1989. Current 
protocols in molecular biology. John Wiley & Sons, New York. 
Bagdasarian, M. M., E. Amann, R. Lurz, B. Ruckert, and M. 
Bagdasarian. 1983. Activity of the hybrid frp-iac (tac) 
promoter of Escherichia coli in Pseudomonas putida. 
Construction of broad-host-range, controlled-expression 
vectors. Gene 26:273-282. 
48 
Barletta, R. G., D. D. Kim, S. B. Snapper, B. R. Bloom, and W. 
R. Jacobs, Jr. 1992. Identification of expression signals of the 
mycobacteriophages Bxbl, LI and TM4 using the Escherichia-
Mycobacterium shuttle plasmids pYUB75 and pYUB76 designed 
to create translational fusions to the lacZ gene. J. Gen. 
Microbiol. 138:23-30. 
Kaneda, S., and K. Yabu. 1983. Purification and some properties 
of p-lactamases from Mycobacterium smegmatis. Microbiol. 
Immunol. 27:191-193. 
McFadden, J. J., P. D. Butcher, R. J. Chiodini, and J. Hermon-
Taylor. 1987. Determination of genome size and DNA 
homology between unclassified Mycobacterium species isolated 
from patients with Crohn's disease and other mycobacteria. J. 
Gen. Microbiol. 133:211-214. 
McKenney, K., H. Shimatake, D. Court, U. Schmeissner, C. 
Brady, and M. Rosenberg. 1981. A system to study 
promoter and terminator signals recognized by Escherichia coU 
RNA polymerase. In J. G. Chirikjian and T. S. Papas (Eds.), Gene 
Amplification and Analysis, vol. 2. Elsevier, North Holland, pp. 
383-414. 
Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring 
Harbor, New York: Cold Spring Harbor Laboratory. 
Miller, J. H. 1992. A short course in bacterial genetics. Cold 
Spring Laboratory press, Cold Spring Harbor, N. Y. 
Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular 
cloning: A laboratory manual. Cold Spring Harbor Laboratory 
Press, Cold Spring Harbor, N. Y. 
Sirakova, T. D., S. S. Bardarov, J. I. Kriakov, and K. I. 
Markov. 1989. Molecular cloning of mycobacterial promoters 
in E. coli. FEMS Microbiol. Lett. 59:153-156. 
49 
Tartof, K. D. and C. A. Hobbs. 1987. Improved media for 
growing plasmid and cosmid clones. Bethesda Res. Lab. Focus 
9:12. 
Thomas, T. J., R. E. Andrews, Jr., and C. O. Thoen. 1992. 
Molecular cloning and characterization of Mycobacterium 
paratuberculosis promoters in Escherichia coU. Vet. Microbiol. 
32:351-362. 
Timm, J. M., G. Perilli, C. Uez, J. Trias, G. Orefici, L. Fattorini, 
G. Amicosante, A. Oratore, B. Joris, J. M. Fr'ere, A. P. 
Pugsley, and B. Gicquel. 1994. Transcription and 
expression analysis using lacZ and phoA gene fusions of 
Mycobacterium fortuitum p-Iactamase genes cloned from a 
natural isolate and a high level p-lactamase producer. Mol. 
Microbiol. 12:491-504. 
Tsang, T., V. Copeland, and G. T. Bowden. 1991. A set of 
cassette cloning vectors for rapid and versatile adaptation of 
restriction fragments. Biotechniques 10:330. 
Whipple, D. L., R. B. Le Febvre, R. E. Andrews, Jr., and A. B. 
Thiermann. 1987. Isolation and analysis of restriction 
endonuclease digestive patterns of chromosomal DNA from 
Mycobacterium paratuberculosis and other Mycobacterium 
species. J. Clin. Microbiol. 25:1511-1515. 
50 
CHAPTER 3. IDENTIFICATION OF GENE EXPRESSION 
SIGNALS IN Mycobacterium paratuberculosis. 
A paper to be submitted to the Journal of Bacteriology 
John P. Bannantine, R. G. Barletta, C. 0. Thoen and R. E. Andrews, Jr. 
ABSTRACT 
Ten novel promoter-contciining clones were isolated from a 
Mycobacterium paratuberculosis DNA library cloned in the promoter 
selection vector pYUB76. The promoter-containing inserts were 
identified by expression of the promoterless lacZ reporter gene of 
pYUB76 and sequenced. The promoters exhibited a wide range of 
strengths, as indicated by their corresponding p-galactosidase 
reporter activities, p-galactosidase activity was determined in two 
hosts, £ coli and M. smegmatis, to assess diversity in 
transcription/translation signal recognition. The transcriptional or 
translational start signals were not recognized at similar levels in the 
two hosts. Those clones which exhibited the strongest p-galactosidase 
expression in M. smegmatis were studied further. Primer extension 
was used to locate the transcription start sites within the cloned 
fragments. Predicted open reading frames and codon usage were 
identified by computer analysis. Database searching for homologous 
sequences using the BLAST method revealed limited homologies. The 
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promoter regions characterized in this study were compared with 
those of several previously reported Mycobacterium promoters and a 
consensus promoter sequence was established. Hexanucleotide 
sequences centered approximately 35 and 10 base pairs upstream 
from the transcription startpoints did not correspond to the consensus 
hexanucleotides of Escherichia coU promoters. 
INTRODUCTION 
Characterization of mycobacterial promoter structure has 
lagged well behind that of other bacterial systems. A detailed 
analysis of Mycobacterium paratuberculosis promoters may provide 
an increased understanding of genetic expression in mycobacteria 
and the extent of divergence in gene expression from other bacteria. 
Despite the importance of members in the genus Mycobacterium due 
to their pathogenic nature, researchers are reluctant to enter this 
field of study because genetic manipulation of these organisms can 
be frustrating and dangerous. Mycobacteria are among the most 
difficult prokaryotes to lyse due to the thick lipid-rich composition of 
their cell walls. Indeed, chemical or enzymatic lysis is relatively 
tedious requiring long periods of time, and mechanical disruption 
may still result in some incomplete lysis (Hurley etal, 1987; Hines et 
al, 1991). They are also slow-growing and refractile to genetic 
exchange by laboratory methods. For these reasons, M. 
paratuberculosis is an underdeveloped genetic system. To date, only 
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four genes have been cloned and sequenced (Stevenson etal, 1991; 
Gilot etal., 1993; Green etal., 1989; Hance etal., 1989) and only two 
promoters have been characterized in this species (Murray etal., 
1992; Thomas etal., 1992). No composite class transposons or 
phages have been discovered in this species. A method of genetic 
exchange has only recently been established (Foley-Thomas et ah, 
1995). By contrast, there are over 160 characterized Escherichia coli 
promoters that have been assembled and analyzed in detail (Hawley 
and McClure, 1983; O'Neill, 1989). 
Recently, some studies have focused on cloning mycobacterial 
promoters (Sela and Clark-Curtiss, 1991; Barletta etal., 1992; Das 
Gupta etal., 1993; Thomas etal., 1992; Timm etal., 1994). The 
limitations of these studies are that cloned promoter fragments were 
not sequenced (Barletta etal., 1992; Timm etal., 1994) and 
transcription start site mapping was either performed with E coli 
RNA (Sela and Clark-Curtiss, 1991) or not at all (Barletta etal., 1992; 
Das Gupta etal., 1993). 
The promoter selection vector pYUB76 has been used to clone 
expression signals from mycobacteriophages (Barletta etal., 1992). 
This vector replicates in E. coli as well as Mycobacterium smegmatis 
and has the following features: 1) a truncated reporter p-
galactosidase gene devoid of promoter, ribosome-binding site and 
initiation codon; 2) a mycobacterial replicon (oriM), and an E. coli 
replicon {colEl); 3) a kanamycin-resistance gene that is expressed in 
both E. coli and mycobacteria. Activation of the reporter gene 
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depends on providing adequate transcriptional and translational 
initiation signals upstream. Furthermore, the ATG or GTG initiation 
codons of the translational signal derived from the insert must be in 
the same reading frame as lacZ. 
This study was undertaken to extend the current knowledge of 
promoter architecture and gene expression in M. paratuberculosis by 
cloning and characterizing additional promoter elements. Using these 
data, a mycobacterial consensus promoter sequence was assembled. 
MATERIALS AND METHODS 
Bacterial strains and plasmids. M. paratuberculosis ATCC 
19698 was provided by D. Whipple NADC, Ames, lA and served as 
the source from which genomic DNA was isolated. Escherichia coU 
DHIOB (Gibco-BRL, Gaithersburg, MD) served as the strain for routine 
plasmid maintenance and isolation. The shuttle vectors pYUB75 and 
pYUB76 (Barletta etal, 1992) and Mycobacterium smegmatis 
mc2l55 were provided by R. Barletta, Department of Veterinary 
Science, University of Nebraska, Lincoln, NE. These two plasmids 
have a kanamycin resistance marker for selection, contain a 
promoterless lacZ gene, and can replicate in both E. coli and M. 
smegmatis. 
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Growth conditions and extraction of M. 
paratuberculosis DNA. For genomic DNA isolation, M. 
paratuberculosis was grown in Middlebrook 7H9 broth (Difco, Detroit, 
MI) containing 0.5% Tween-80, OADC enrichment (Difco) and 2 mg/L 
mycobactin J (Allied Monitor, Fayette, MO). The cells were harvested 
after 5 weeks of growth in tissue culture flasks (Corning, Inc., 
Corning, N. Y.) at 37oC. M. paratuberculosis pellets (1 to 3 g) were 
frozen at -70oC and genomic DNA was extracted by the method of 
Whipple etal. (1987). 
DNA cloning. Genomic DNA from M. paratuberculosis was 
digested with 5a u3AI and fractionated by agarose gel 
electrophoresis, and fragments from 100 to 2000 bp were purified 
by electroelution. Approximately 0.5 (xg of purified genomic DNA 
fragments was cloned into 1 |ig of dephosphorylated, ^amHI-cleaved 
pYUB76 in a final volume of 10 jxl. The cloning of 5au3AI M. 
paratuberculosis chromosomal fragments into the BamHl site 5' to 
the lacZ gene resulted in the construction of translational fusions, 
where properly positioned M. paratuberculosis promoters drive the 
transcription of lacZ. The ligation mixture was used to transform E. 
coli DHIOB by electroporation. Potential transformants were plated 
on Luria Bertani (LB) medium containing 50 |ig/ml kanamycin. The 
LB medium also contained 5-bromo-4-chloro-3-indolyl-p-D 
galactopyranoside (Xgal) added to each plate as described by 
Sambrook et al. (1989). Blue colonies on this medium were 
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considered to have a cloned M. paratuberculosis promoter sequence. 
The selective media for M. smegmatis electroporations was 
Middlebrook 7H10 agar (Difco, Detriot, MI) with 50 ixg/ml kanamycin 
and Xgal added as described above. Conditions for the construction 
of pAJBGO are described elsewhere (Bannantine etal., in 
preparation). 
Quantitative p-galactosidase assays. The p-galactosidase 
assays for E. coli were performed as described by Miller (1972) with 
one modification. The minimal growth medium recommended by 
Miller was substituted for LB medium. |3-galactosidase assays for M. 
smegmatis were performed as described by Barletta et al, 1992. For 
all experiments, p-galactosidase activity is expressed as Miller units 
of activity (Miller, 1972). 
RNA extraction. Total cell RNA was isolated from E. coli by 
routine methods (Ausubel etal, 1989). Total cell RNA was extracted 
from M, smegmatis using the protocol described by Bashyam and 
Tyagi (1994). 
DNA sequencing. Sequencing reactions were performed 
manually with Sequenase® Version 2.0 sequencing kit (United States 
Biochemical Corporation, Cleveland, OH) for generating molecular 
weight markers with phage Ml3 to resolve the size of the primer 
extension products. The lacZ fusion constructs in pYUB76 were 
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sequenced by using the Tag DyeDeoxy® Terminator Cycle Sequencing 
Kit (Perkin Elmer/Applied Biosystems Division (PE/ABD), Foster City, 
CA). Each sequencing reaction included 100 ng of template DNA and 
10 pmol of sequencing primer in a total volume of 20 ^il. Each 
reaction underwent 25 cycles (98oC for 15 s, 50oC for 2 s, 60oC for 4 
min) in the GeneAmp PCR System 9600 thermal cycler (Perkin-
Elmer, Norwalk, Conn.). The sequencing products were purified 
through Centri-Sep columns (Princeton Separations, Adelphia, NJ.) 
and were loaded onto 6% denaturing polyacrylamide gels in an 
automated sequencer (373A DNA Sequencer; PE/ABD). Template 
DNA for automated sequencing was prepared by one of two methods; 
PEG preparation (Tartof and Hobbs, 1987) or Qiagen extraction. The 
Qiagen miniprep was performed according to the instructions of the 
manufacturer (Qiagen). 
To sequence lacZ+ inserts from pYUB76, synthetic 
oligonucleotides with the following sequences 
5'-CATTATTATCATGACATTAACC-3' (JB807) and 
5'-GTGCTGCAAGGCGATTAAGTTG-3' (JB808) were employed. 
These primers were originally designed by Raul Barletta (University 
of Nebraska, Lincoln, NE) to PCR amplify inserts from pYUB75 or 
pYUB76. Other primers used in this project were designed to 
sequence further into the pAJB86 insert. These primers are shown 
in Table 1. 
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Table 1. Deoxyribonucleotide primers 
Primer Sequence Nucleotide position 
in the lacZ fusion^ 
DATB86: 
JB957 5'-TGCTCGACCTGGAGCGGATCAG-3' -1,319 to -1,298 
JB1054 5'-TGCrCGGTGCCCAGTrCGTCAT-3' -1,019 to-998 
JB958 5'-ACACCGAGATCGACCTGGAT-3' -534 to-515 
JB923 5'-GATGAGATCCTGCAGGCGTG-3' -301 to -282 
JB924 5'-GTCCGCGTGCTCCAGGAG-3' -10 to +8 
PATB125: 
JB499 5'-TGATGCCGGCGACCTCCrGGT-3' -1,111 to-1,091 
JB500 5'-ATCCGACCACGCCCGGAATTG-3' +29 to +49 
a Nucleotide position designations are all relative to the 
transcription start site. 
Computer analysis of DNA sequences. Sequence 
alignments were made by using the software package SeqEd^^^ 
(Version 1.0.3; PE/ABD), Basic Local Alignment Search Tool (BLAST; 
Altschul et aL, 1990) was used for database homology searches and 
were performed via email of the sequence queries to 
blast@ncbi.nlm.nih.gov or through the world wide web using the 
biologist's control panel (URL address; 
http://gc.bcm,tmc.edu:8088/bio/bio_home,html). The ORFs were 
identified with either Codon Usage or Gene Finder in PERT or 
Sequencher® 3.0. The Wisconsin package GCG (Devereux et al., 1984) 
was used to identify conserved regions. 
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Slot Blot Hybridization analysis. Samples of M. smegmatis 
total cell RNA were heat and chemically denatured prior to 
application on a Hybond-N nylon membrane (Amersham, Arlington 
heights, IL). RNA samples were applied with a filtration manifold 
consisting of a lucite block containing a number of slots (slot blotting 
apparatus; Gibco-BRL). Conditions for prehybridization, hybridization 
and washes were performed by routine methods (Sambrook, etal, 
1989). The radioactive probes used for hybridization consisted of [a-
32P]dATP-labeled 3.2-kb EcdRl fragment from pCClac5 (Cupples and 
Miller, 1988) and 16S and 23S rRNA from M. smegmatis mc2l55 
(pYUB76). Plasmid pCClac5 contains the 3.2-kb EcdBl fragment 
carrying lacZ. Unincorporated nucleotides were separated from 
labeled probe by two consecutive precipitations with ethanol in the 
presence of 7.5M ammonium acetate. Slot blot signals were 
quantitated by computer scaning the autoradiogram into the 
shareware program NIH image and performing an internal 
calibration. The levels of RNA used were adjusted by first 
normalizing the relative amounts of RNA used in the rRNA slots then 
similarly adjusting the RNA levels in the lacZ slots. 
Primer Extention analysis. Total cell RNA from M. 
smegmatis strains harboring the lacZ fusions was used as a template 
for the synthesis of cDNA products from 5'-end-labeled synthetic 
oligonucleotide primers. The two primers (JB808 and JB1058, 5'-
AGTCACGACGTTGTAAAACGACG-3' which correspond to nucleotides 
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+69 to +48, and +27 to +5 of lacZ in pYUB76, respectively. The "T" 
nucleotide in the BamHl site is defined as +1) were end labeled by T4 
polynucleotide kinase (Promega, Madison, WI) with [x-^zpjATP 
(Amersham). The annealing and reverse transcription reactions 
were performed with the AMV reverse transcriptase primer 
extension system following the instructions of the manufacturer 
(Promega). The products of the reactions were visualized by 
autoradiography after separation in 6% urea-polyacrylamide gels. 
RESULTS 
Cloning M. paratuberculosis promoters in pYUB76. To 
effectively study promoter structure in M. paratuberculosis, a 
genomic library was cloned in the promoter-probe vector pYUB76 
(Barletta et al., 1992). 1,774 kanamycin resistant colonies were 
obtained after electroporation of the pYUB76 library into E. coli 
DHIOB. Of those colonies, 74 were lacZ+ (4.2%), indicative of 
promoter-containing clones. Forty-six randomly selected lacZ'^ E. coli 
clones were extracted and analyzed with restriction endonucleases. 
To assess the extent of divergence of M. paratuberculosis promoters 
from those of E. coli, the p-galactosidase activities supported by the 
promoters in E. coli were measured and compared with their 
corresponding activities in mycobacteria (Figure 1). Six of ten 
mycobacterial promoter elements functioned poorly in E. coli. These 
cloned sequences drove expression of p-galactosidase in M. 
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smegmatis at varying levels or strengths, according to histochemical 
screening and quantitative assays (Figure 1). In addition, the entire 
1,774 clone library was pooled, amplified and electroporated into M 
smegmatis. Twenty-four lacZ positive, kanamycin resistant colonies 
M. smegmatis 
• E. coll 
lacZ fusion 
Figure 1. Relative expression rates of the pYUB76::iacZ fusions in 
E. coli and M. smegmatis. p-gcdactosidase Units are units 
of activity defined by Miller (1972). Experiments were 
performed in triplicate with the error bars representing 
the standard deviation of the mean. 
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were obtained. Table 2 summarizes the p-galactosidase activity for 
the lacZ fusions in M. smegmatis only. The twelve constructs that 
displayed the strongest p-galactosidase expression from both 
experiments were sequenced. 
Table 2. p-galactosidase expression levels of pYUB76::7acZ fusions 
in M. smegmatis. 
Construct Colony color Initial p-galactosidase units^ 
Selection 
pYUB76 White Both 0.10±0.12 
pAJBSOS Dark Blue M. smegmatis 16.4±1.7 
pAJB300 Dark Blue M. smegmatis 38.1+7.3 
pAJB304 Blue M. smegmatis 1.8±0.47 
pAJB301 Dark Blue M. smegmatis 20.6+4.5 
pAJB73 Light Blue £ coli 0.29+0.22 
pAJB305 Blue M. smegmatis 8.2±1.2 
PAIB86 Blue E. coli 5.2±1.6 
pAJB60 Blue E. coli 2.5+0.75 
pAJB125 Blue E. coli 5.7±0.87 
PAJB89 Light Blue E. coli 0.29±0.21 
a P-galactosidase units are measured in Miller units of activity 
(Miller, 1972). The reported figures are the average of three 
trials + the standard deviation. 
DNA sequence analysis. Sequence analysis revealed that 
two of the twelve constructs were identical to the insert in pAJB300 
and one was identical to pAJB304. Of the nine novel lacZ+ constructs 
that have been sequenced, only one (pAJB86) was not completely 
sequenced. The pAJB86 insert was too large and repeated attempts 
at sequencing further into its insert did not generate reliable 
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sequence data. Their sizes, % guanine plus cytosine (%G+C) content, 
and other information are presented in Table 3. The %G+C of 
sequenced inserts agrees well with the published figure of 66-67% 
for M. paratuberculosis (McFadden etal., 1987). The putative open 
reading frames (ORFs) have also been identified by computer 
analysis and confirmed for conditions specific to iacZ expression in 
pYUB76 (i. e. all cloned sequences must contain a promoter 
Table 3. Sequence data from lacZ^ M. smegmatis contructs. 
Construct name Insert %GC content No. of Mycobacterial 
Size (bp) amino acids in fusion 
PAJB303 610 67.2 95 
PAJB300 412 66.1 24 
PAJB304 663 68.2 7 
PAJB301 292 70.9 61 
pAJB73 104 69.2 15 
PAJB305 559 71.0 10 
PAJB86 >1,800 66.3 20 
pAJB60 531 66.5 NDa 
pAJB125 1,660 60.8 81 
^ ND, not determined 
structure, ribosome binding site, a start codon, and must be in frame 
with the ninth codon (GUC) of lacZ). The complete nucleotide 
sequences as well as the deduced ORFs are shown in Appendix A. 
The potential ribosome binding sites (KBS) are also indicated in 
Appendix A. BLAST searches of Genbank and EMBL nucleic acid 
databases showed different degrees of homology to genes of other 
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organisms (Appendix B). Several of the homologies obtained from 
the databases were sequences from Streptomyces species. This was 
not suprising since Streptomyces is phylogenetically related to 
Mycobacterium. BLAST searches were also performed on the 
deduced amino acids of M. paratuberculosis that participate in the 
lacZ fusions (Appendix C). Among the strongest amino acid matches 
were the human collagen alpha 1 chain with the M. paratuberculosis 
ORF from pAJB301. This match produced a sum probability of 
0.00015 (the smaller the number, the closer the match). 
The high G+C content in M. paratuberculosis genomic DNA made 
it particularly difficult to sequence. The best results were obtained 
when high temperature denaturation and extension conditions were 
used with Taq polymerase and the reactions were combined with 2% 
final concentration of dimethyl sulfoxide. An average reading length 
of 328 bp was obtained from successful reactions. 
Codon Usage. A compilation of the codons employed in the N-
terminal mycobacterial ORFs which participated in the lacZ fusions is 
presented in Figure 2. As has been found for other microorganisms, 
there is a correlation between the %G+C content of the genome and 
the percent of codons with a guanine or cytosine in the third position 
(Muto and Osawa, 1987). The data compiled for M. paratuberculosis 
in this study shows that 73% of the codons contain a dG or dC in the 
third position whereas codons ending in dT and dA are quite rare, at 
15 and 12%, respectively. 
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Slot Blot Hybridization analysis. To estimate 
transcriptional activity from the lacZ fusions, slot blot hybridization 
experiments were performed. Total cell RNA from the lacZ positive 
M. smegmatis strains was applied to a nylon membrane and 
hybridized (Figure 3) as described in Materials and Methods. Based 
on these data, M. smegmatis (pAJB303) showed the highest 
transcriptional activity. No transcriptional activity was detected in 
M. smegmatis (pYUB76) by either northern hybridization analysis 
(data not shown) or slot blot analysis (Figure 3). Figure 4 
summarizes the transcriptional and translational data in conjunction 
with schematic maps of all the lacZ fusions. 
F TTT 0 
F TTC 4 
L TTA 0 
L TTG 2 
S TCT 2 
S TCC 2 
S TCA 0 
S TCG 4 
Y TAT 0 
Y TAC 0 
* TAA 0 
* TAG 0 
C TGT 0 
C TGC 3 
* TGA 0 
WTGG 3 
L CTT 4 
L CTC 10 
L CTA 2 
L CTG 15 
P CCT 3 
P CCC13 
P CCA 2 
P CCG14 
H CAT 4 
H CAC 8 
a CAA 3 
a CAG 2 
R CGT 0 
R CGCll 
R CGA 7 
R CGGIO 
I ATT 1 
I ATC 7 
I ATA 2 
M ATG 8 
T ACT 0 
T ACC 8 
T ACA 3 
T ACG 6 
N AAT 2 
N AAC 5 
K AAA3 
K AAG 1 
S AGT 0 
S AGC 5 
R AGA 1 
R AGG 1 
V GTT 5 
V GTC 9 
V GTA 6 
V GTG 10 
A GCT 7 
A GCC 14 
A GCA 0 
A GCG 12 
D GAT 12 
D GAC 8 
E GAA 7 
E GAG 9 
G GGT 6 
G GGC 15 
G GGA 1 
G GGG 7 
Figure 2. Codon usage within the seven open reading frames found 
in the pYUB76;:JacZ fusions. A total of 313 codons went 
into this compilation. 
Figure 3. Quantitation of steady state RNA from M. smegmatis 
harboring pYUB76::iacZ fusions. Total cell RNA from M. 
smegmatis was quantitatively spotted to the nylon 
membrane shown and hybridized with either radiolabeled 
rRNA from M. smegmatis (left column) or a /acZ-specific 
fragment from pCClac5 (right column). The strength of the 
signals was determined using an internal calibration in the 
Computer program NIH image. The strain designations cire 
as follows; AJB-217: M. smegmatis (pAJB125); AJB-173: M. 
smegmatis (pAJB86); AJB-174: M. smegmatis (pAJB89); 
AJB-112: M. smegmatis (pYUB76); AJB-201: M.smegmatis 
(pAJB73); AJB-274: M. smegmatis (pAJB304); AJB-275: M 
smegmatis (pAJB305); AJB-207: M. smegmatis (pAJB60); 
AJB-270: M. smegmatis (pAJB300); AJB-271: M. smegmatis 
(pAJB301); AJB-273; M. smegmatis (pAJB303). 
Construct rRNA lac % Density 
PAJB125 
pAJB86 
pAJB89 
PYUB76 
PAJB73 
PAJB304 
PAJB305 
PAJB60 
PAJB300 
PAJB301 
PAJB303 
Figure 4. Schematic diagram of the pYUB76::iacZ fusions along with their mRNA and reporter 
activity levels. The construct maps are drawn to scale and the translational 
efficiencies are shown for both the M. smegmatis and E. coli backgrounds. The 
constructs are listed from highest amount of lacZ fusion mRNA to lowest amount as 
measured by percent density in Figure 3, The pAJB60 lacZ fusion is also shown here 
for the sake of comparison only since the size of the open reading frame and 
location of a promoter structure could not be determined. 
Steady state 
RNA levels in 
M. smeamatis 
PAJB303 53.40 
39.14 PAJB300 
18.28 PAJB304 
10.52 PAJB301 
pAJB73 
PAJB305 
pAJB86 
pAJB60 
pAJBI 25 
R-aalactosldase activity 
M. smeamatis E. coli 
16.4±1.7 
38.1+7.3 
1.8+0.47 
20.6+4.5 
0.29+0.22 
8.2+1.2 
5.2+1.6 
2.5±0.75 
5.7±0.87 
>0.2 
>0.2 
0.6+0.24 
0.4+0.21 
14.7+1.98 
0.3+0.13 
4.5+0.63 
0.3+0.33 
1.5+0.47 
00 
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Primer Extention analysis. To localize the promoter region 
within the cloned inserts, the transcription start sites were mapped. 
The mRNA initiation sites of the cloned lacZ fusion transcripts were 
identified by primer extension with reverse transcriptase and a 5'-
end-labeled oligonucleotide primer. Comparison of the 
electrophoretic mobility of the primer extension product with that of 
the products of the dideoxy sequencing reactions in Figures 5, 6 and 
7 was used to map the 5' end of the transcripts. Primer extension 
products were generated for the pAJB73 (Figure 5), pAJB86, 
pAJBSOO, pAJB301, pAJB303, pAJB304, and pAJB305 constructs 
(Figure 6). The transcripts from pAJB300 and pAJB304 were 
mapped with the JB808 primer (Figure 7) and the JB1058 primer 
(Figure 6). Several extension products appeared on the 
autoradiogram of the primer extensions performed with the JB808 
primer (Figure 7). A defined extension product could not be reliably 
determined for pAJB300 when using JB808, however, a 101 bp 
product was identified for pAJB304 (Figure 7). The JB1058 primer 
produced an extension product for pAJB304 that was 5 bp longer 
than that produced with the JB808 oligonucleotide (Figure 6). The 
startpoint of the pAJB303 transcript was not precisely determined 
due to the large size of the cDNA product (too large to comigrate with 
resolvable DNA sequencing ladders (Figure 6)). Therefore an 
estimate of the extension product was made using radiolabeled 
0X174 DNA markers digested with Hinfl (data not shown). Primer 
extension products were not observed for pAJB60 or pAJB89. 
Figure 5. Primer extension analysis of pAJB7 3 ::iacZ. Details of the 
experiment are described in Materials and Methods. The 
location of the 81 and 82 nucleotide (nt) extension 
products of the transcript from pAJB73 (lane 1) are 
indicated in the left hand margin. The lanes labeled G, A, 
T, and C contain the dideoxy sequencing reactions with the 
M13 DNA template. Lanes 2,3, and 4 contain failed primer 
extension reactions from pAJB60, pAJB89, and pAJB301, 
respectively. 
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1 2 3 4  G A T  
Figure 6. Primer extension analysis of lacZ fusion transcripts from 
pAJBSOO (lane 1), pAJB301 (lane 2), pAJB303 (lane 3), 
pAJB86 (lane 4), pAJB305 (lane 5), pAJB125 (lane 6), 
pAJB304 (lane 7), pAJB60 (lane 8), and pAJB89 (lane 9). 
The position of the primer extension products are indicated 
by arrows along with the nucleotide (nt) length of the 
product. An extension product was not detected for either 
pAJB60 or pAJB89. Details of the experiment are 
described in Materials and Methods. 
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G A C T 1 2 3 4 5 6 7 8 9 G A C T  
400 nt -> 4k 
S <~ 340 nt 
290 nt --> 
261 nt --> 
' t r .  
m 
- .r.-* <--199 nt 
. |<»V 
130 nt "> 
W"" •* 
•m 
.1*. 
•M 
<-- 65 nt 
Figure 7. Primer extension analysis of pAJB300::iacZ and pAJB304::/acZ 
with the JB808 primer. Details of the experiment are 
described in Materials and Methods. The location of the 
101 and 87 nucleotide (nt) extension products of the 
transcript from pAJB304 (lane 2 and 3) and the control 
(lane 4) are indicated in the left hand margin. The lanes 
labeled G, A, T, and C contain the dideoxy sequencing 
reactions with the Ml3 DNA template. 
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Putative ribosome binding sites in M. paratuberculosis 
mRNA. McLaughlin et al. (1981) observed that the ribosome 
binding sites of prokaryotic mRNA exhibit complementarity to the 3' 
region of 16S rRNA. With the exception of pAJB89 and pAJB60, a 
region of homology to the 3' terminus of M. leprae 16S rRNA 
followed after several bases by an initiation codon and an open 
reading frame for translation was observed for all the lacZ fusions 
(Appendix A). Nucleotides that may base pair with rRNA are 
highlighted with oversize letters in Table 4. The predicted free-
energy of base pairing (AG) of these ribosomal binding sites with 16S 
rRNA, calculated according to the rules of Tinoco etai. (1973), ranged 
from -3.6 to -19 Kcal. 
Determination of a consensus promoter sequence. The 
eight promoters that had their transription start sites identified by 
primer extension analysis were aligned as shown in Table 5. The 
frequency at which any one nucleotide occurred at each position 
extending from +1 to -40 was recorded (Figure 8). From this 
analysis, no consensus "£ coli-like" promoter sequences were found. 
Instead, single nucleotides at various spacing were shown to occur at 
greater than 60% frequency. 
The -35 and -10 regions of all the mycobacterial promoters 
that contain an experimentally determined transcription start site 
were assembled (Table 6). Frequently occurring nucleotides in a 
Table 4. Nucleotide sequences of putative M paratuberculosis ribosome binding sites 
Construct Nucleotide Sequence AG (kcal) Position of 
Start Codon 
pAJB303 UGGGCUGGGCGGGCUUGCGGAAUCACCGAAAAGAUAAGUGAAAAUG -6.0 +94 
pAJB300 GGACGAUUUCACGAACCUGUGUACGCAAGUUACAGUUAUCUCCAUG -4.8 +96 
pAJB304 GAGGUGGACGGGAGGUCGUCGAUG -15 +22 
pAJB301 CGACCAGGGUUUCAUGCACGGCGCUGGCGACCAUCAGCCUGCGGUG -5.6 +59 
pAJB73 UGCUCGAGCUCGAGCUCGGUGUG -3.6 +15 
pAJB305 GCGACAAGGCAAUGUUGUCGGUACCGGAUGAGAUGGUCUGUUCAUG -10 +79 
pAJB86 GGCUACCGCGUCGAAGCCGGAACCAUGACUGGCGUUCGGCAGAAUG -8.0 +118 
pAJB89 UCCGACAUGGCGCCCGGAUAGAAGGAGGCGAUCCCGUC -19 NPa 
pAJB125 AGGAGGUCGCCGGCAUCAGGGCCGGCACCACGUUGUUGCGCCACGUG -19 +76 
16S rRNA 3' AUUCCUCCACUA 
3 ND = Not determined 
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Table 5. Alignment of the transcription start sites determined 
using the JB1058 primer in the pYUB76::iacZfusions. 
-35 region -10 region +1 Construct 
AGGGCGGTGGCGTCGCCGGTGTAGCCGAACGGCACGTGCGCGT PAJB303 
AGACCCTGACGCrGGCCGACCTCGGCGCGCAGCCGACCGCGCA pAJBSOO 
ACGCCAAGGACAACGGCCGTATCCGGTACCAACGGGTGTGCG PAJB304 
GGTCCAGTACACCGCGAGTrCGCGCACGCTGGCCGGCAGCGTCr pAJBSOl 
GTGTGCCGCTTGAACCGGCCCAGCTCCCGCrCCAGGGTGACGT pAJB73 
GGCAGTTGTTGGAGTTTCTGTCGGACGG'lTGGTTGGCGGCATr pAJB305 
ACTCCCGATGACGTTGCACGGCTGGGATTAACGGTCCGCGTGCT pAJB86 
GCATCATTAAAGATCGANGGCGCCGGGNTCATGTCCCTTCACC PAJB125 
given position are shown in bold in Table 6. Based on these data, a 
consensus for the -35 region was established as T(G/T)G(A/C)GT. 
The -10 region was established as CAGCCG. The -35 region is 
typically defined by a thymine in the first position of the hexamer, 
which occurs in 82% of the sequences compiled in Table 6. 
The guanine nucleotide was never found to occupy this first position. 
A guanine nucleotide at the fifth position of the -35 hexameric region 
occurred in 7 of the 9 M. paratuberculosis promoters but was not 
observed for any of the promoters in other mycobacterial species. A 
cytosine or adenine had an 88% occurrence in the fourth position of 
the -35 hexamer. The begining of the -10 region is typically defined 
by a pyrimidine (cytosine or thymine) which had an occurrence of 
82%. For M. paratuberculosis promoters defined in this study, both of 
the -10 and -35 regions contained a guanine or cytosine in the last 
position of the hexamer with 78% frequency. An adenine was never 
observed in the sixth position of either region for M. paratuberculosis. 
Figure 8. Distribution of nucleotide bases relative to the transcription start site. Shown is a 
histogram plot of each nucleotide position from -40 to +1 with the relative frequency 
at each location. 
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Table 6. -35 and -10 promoter regions and their spacings in 
mycobacteria. 
Promoter -35 Region -10 Region +1 Initial 
Codon 
Promoters from this study: 
pAJB303 TGGCGT 16 CGGCAC 7 T 92 ATG 
pAJB300 TGACGC 17 CAGCCG 7 A 195 ATG 
pAJB304 AAGGAC 17 CCAACG 7 G 21 ATG 
PAJB301 TCCAGT 20 CTGGCC 9 T 55 GIG 
pAJB73 TGCCGC 20 CTCCAG 7 T 13 GIG 
pAJB305 TGTTGG 17 TGGTTG 7 T 77 ATG 
pAJB86 TGACGT 17 CGGTCC 6 T 116 ATG 
pAJB125 TTAAAG 17 CATGTC 7 C 74 GIG 
Other mycobacterial promoters:^ 
hspOO BCG TTGCAC 17 TAAGAA 6 T 183 ATG 
PAN M. ptb. TCGACA 17 TACACT 7 A 40 ATG 
leSrmA leprae TTGACT 16 ATTAAT 7 G 
leSrRNA M. tub. TTGACT 18 TAGACT 7 T 
cpnOOM. tub. TGCTCA 17 GGCGGC 7 A 29 ATG 
mpbJOBCG CCGATC 17 CATCAG 6 G 176 ATG 
bla fortuitum TTCAAA 19 TACGCT 7 A 0 ATG 
ask smegmatis CCCAQG 17 ACGCTG 7 G 250 GIG 
85A M. tub. TTGACT 22 CGCCTG 7 A 63 ATG 
Mycobacterium T(G/T)G(A/C)GT CAGCCG 
consensus 
E. coli consensus TTGACA 17-19 TAT A AT 
^ Mycobacterium sp. promoter regions as compiled by BCremer et al. 
(1995). Only promoters for which the trcinscription start sites 
are known were included. 
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DISCUSSION 
These studies have established that M. paratuherculosis 
expression signals are capable of driving the expression of p-
galactosidase in M. smegmatis and E coll Based on p-galactosidase 
expression levels in the pYUB76;:7acZ fusion constructs, M smegmatis 
was the preferred host for initial selection of promoter-containing 
inserts when compared with E. coli. The work described herein 
effectively doubles the current state of knowledge regarding 
promoter structure in the entire mycobacterial genus since only nine 
mycobacterial promoters have been previously characterized in the 
detail described here (Kremer etal., 1995). With the exception of 
pAJB60 and pAJB89, all of the sequenced promoters showed clear 
transcriptional initiation signals. Moreover, typical start codons were 
not identified in pAJBGO and pAJB89, even though the reporter gene 
is expressed. Thus, it is unlikely these two constructs contain bona 
fide promoter sequences. Importantly, the combination of screening 
in mycobacterial hosts and use of primer extension analysis 
distinguished false reporter gene activity from bona fide promoter-
containing fragments. 
The ability to recognize M. paratuherculosis gene expression 
signals was variable in E. coli and M. smegmatis depending on which 
host was employed for initial selection of the lacZ fusions. The 
constructs initicilly selected in M. smegmatis, displayed strong 
expression of the reporter gene in M, smegmatis but not in E. coli. 
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For constructs whose initial selection was in E. coli, the reverse was 
observed. Reporter gene expression in both hosts was observed 
only with pAJB86, pAJB89, pAJB73 and pAJB125. It is important to 
note that plasmid copy number between the two hosts was not 
tested. While it is likely that the two hosts maintain different copy 
numbers for the pYUB76::iacZ fusions, there is no a priori reason to 
suspect variable copy number within a single host. 
Strong promoter activity was observed in the lacZ fusion 
constructs of pAJB300, pAJB301, and pAJB303. When comparing the 
Miller units obtained in the quantitative p-galactosidase assay with 
those reported by Barletta eta/. (1992) for cloning mycobacterio-
phage promoters in pYUB76, it was discovered that pAJB300 is 
stronger and pAJB301 and pAJB303 are slightly weaker than the 
cloned mycobacteriophage promoters. These data make pAJB300 a 
particularly interesting clone since bacteriophage promoters are 
typically classified as strong promoters. The cloned pAJB300 or 
pAJB303 inserts may be good candidates for expression of 
heterologous antigens in M. bovis BCG for recombinant vaccine 
development (Stover eta/., 1991; Stover etal, 1993) because of their 
high level expression of lacZ in this study. The P-galactosidase 
assays indicate that pAJB300 was translationally the most active 
with pAJB303 and pAJB301 a comparable second. 
The slot blot hybridization of M. smegmatis RNA was 
performed to quantitate steady state levels of the lacZ fusion 
message. Thus, pAJB303 might contain the strongest promoter. 
84 
Alternatively, the pAJB303 message might be more stable. The 5' 
leader sequence of some stable transcripts such as the T4 
bacteriophage gene 32 or the E. coli ompA can stabilize other 
sequences fused downstream from them (Ehretsmann etal, 1992). 
For example, the lacZ transcript has a half-life of 90 seconds, but a 
gene 32::lacZ fusion has a half-life of 20 min (Ehretsmann et al., 
1992). 
The use of the Taq method for sequencing the fragments cloned 
in pYUB76 gave the best results since it enabled high temperature 
polymerization of GC-rich templates. Even though the complete 
nucleotide sequence was not determined for pAJB86, the promoter 
region was clearly identified. 
The ribosome binding site or Shine-Dalgarno sequence (Shine 
and Dalgarno, 1974), which orients the 3 OS ribosomal subunit to the 
transcript, is a purine-rich region based on the sequence of the 16S 
rRNA of M. leprae (Estrada-G etal, 1988). Although we have not 
identified initiation codons directly by ammino acid sequencing, eight 
of the ten lacZ fusion mRNAs display regions of complementarity to 
the 3' region of M. leprae 16S rRNA followed by a possible initiation 
codon and an open reading frame. The free-energies of interaction 
(AG) for the proposed ribosome binding sites vary from -3.6 to -19 
Kcal as compcired to -9.4 Kcal for the prototype E. coli ribosome 
binding sequence AGGA (McLaughlin etal., 1981). 
The codon usage data compiled for M. paratuberculosis in this 
study shows that 73% of the codons contain a dG or dC in the third 
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position whereas codons ending in dT and dA are quite rare, at 15 
and 12%, respectively. These figures are consist with codon usage in 
M. leprae (Honore eta/., 1993) where 75% of the codons end in dG or 
dC and codons ending in dT and dA are 17 and 8%, respectively. 
Some ambiguity exists with the primer extension data 
regarding pAJB304. The JB808 primer produced a cDNA product 101 
bp in length that was five base pairs downstream from the start site 
identified using the JB1058 primer. Reasons for this discrepency 
have yet to be determined, but it is most likely a premature stop 
with the JB808 primer since the extension product obtained with the 
JB1058 primer is much "cleaner" with no premature stops. Direct 
evidence that the sequence upstream from the mapped transcription 
start point acts as the promoter will be obtained by deletion analysis, 
RNA polymerase binding studies, or by promoter mutations for all of 
the lacZ fusion constructs. 
The cDNA product obtained for the pAJB303 construct was too 
large to comigrate with resolvable sequencing ladders. Therefore the 
length of that extension product could not be determined to single 
base pair accuracy. A long extension product from pAJB303 is 
consistent with the long mycobacterial ORF that was cloned in this 
construct. Primer extension products have been shown to be as long 
as 1 kb (Kroll etai., 1991). 
All eight of the transcriptionally mapped promoters display 
striking conformity in their -35 and -10 regions with the 
corresponding consensus nucleotides (T, G/T, G, A/C, G, T and C, A, G, 
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C, C, G, respectively). Indeed, bases at four out of twelve positions 
are invariant in all eight promoters and bases at three additional 
positions are conserved in five out of eight promoters (Table 6). 
Moreover, the "spacer" between the -35 and -10 regions (16-20 base 
pairs) corresponds to the preferred interval for prokaryotic 
promoters. Both the conserved nucleotides and the spacing between 
them is consistent with the compilation of other sequenced 
promoters from Bacillus subtilis (Moran etal., 1982) and E. coli 
(Hawley and McClure, 1983). Additional promoter sequences must 
be compared to test or refine the consensus regions. The -35 region 
of the mycobacterial consensus resembles that of E. coli whereas the 
-10 region does not. Upstream regions of mycobacterial genes have 
been shown to have a higher G+C content than their £ coli 
counterparts (Dale and Patki, 1990). This observation was confirmed 
in the present study as the conserved regions possess a G+C content 
of 66.7% compared with 16.7% for the E. coli consensus. As was 
pointed out by Dale and Patki (1990), analysis of the sequence of 
many mycobacterial genes does not reveal any regions upstream 
from the putative translational start position that resemble a 
consensus prokaryotic promoter. The results of this study have, for 
the first time, revealed a mycobacterial consensus promoter. 
With the consensus sequence information established, it 
became of interest to compare experimentally determined M. 
paratuberculosis promoter strengths with the degree of sequence 
conservation in the conserved promoter regions. Theoretically, a 
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DNA sequence containing all of the consensus nucleotides with the 
proper spacing should exhibit the strongest promoter activity. The 
pAJB300 construct has been shown to produce the most reporter 
gene product. Examination of the conserved regions of the pAJBSOO 
construct shows that the -10 region exactly matches the -10 
consensus sequence. Also four of six positions in the -35 region 
matched consensus nucleotides. Similarly, the pAJB303 construct 
was shown to be the most transcriptionally active based on 
quantitative hybridization experiments. The -35 region in pAJB303 
exactly matches the -35 consensus sequence and three positions in 
the -10 region contain consensus nucleotides. 
This study has provided the framework for many future 
studies of promoters in mycobacteria. With these cloned promoters, 
mutations can be created that disrupt spacing and add or remove 
consensus base pairs to observed how this affects promoter strength. 
Deletion analysis or RNA polymerase binding studies could be 
performed to determine the minimum sequence requirement for a 
functional promoter. 
Conditions such as osmolarity, pH, temperature, water 
concentration, etc. could upregulate or downregulate expression of 
the lacZ reporter gene. These laboratory stresses, including exposure 
to oxidative radicals, may mimic the type of environmental changes 
encountered by these intracellular parasites and may provide clues 
as to patterns of gene expression in vivo. Iron-regulated promoters 
could be cloned from mycobactin-dependent strains. To accomplish 
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this, a promoter library would be constructed using pYUB76. M. 
smegmatis clones carrying promoter signals would be identified by 
p-galactosidase production on iron-deficient medium. The final 
screen would involve those promoters that are repressed (white on 
Xgal plates) on iron sufficient medium. These studies could then 
directly contribute to understanding of mechanisms involved in 
mycobacterial pathogenicity. Finally, more mycobacterial promoters 
need to be cloned and characterized in order to further refine the 
consensus sequence. 
The results herein show that M. paratuberculosis sequences can 
serve as promoters in M. smegmatis and occasionally in E. colL 
Promoter-probe studies do not prove that a cloned sequence actually 
has promoter activity in its original context. The fact that 
transcriptional activity in E. coli may be attributed to a fortuitous 
"promoter-like" sequence and not a legitimate mycobacterial 
promoter cannot be ruled out. Future experiments will be focused on 
deletion analysis and ultimately RNA polymerase binding assays to 
presicely define the sequence required for promoter activity. Little 
is known about mycobacterial gene experssion, gene regulation, and 
the influence of environmental conditions on expression levels of 
these cloned promoters. This study represents the most 
comprehensive and detailed analysis of M. paratuberculosis 
promoter elements to date. 
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GENERAL CONCLUSIONS 
The ability to genetically manipulate the mycobacteria, some of 
the first microbial pathogens identified, is much less than a decade 
old. The new tools that make possible the study of gene expression 
in members of this genus will ultimately enhance our understanding 
of the molecular basis of the pathogenicity of M paratuberculosis. 
The most important developments in the molecular analysis of 
M. paratuberculosis have been the characterization of restriction site 
length polymorphisms (Whipple etal., 1989), the characterization 
and sequence determination of the insertion sequence IS900 (Green 
etal, 1989), and the studies on M. paratuberculosis taxonomy which 
indicate a very close relationship with Mycobacterium avium (Thorel 
et al, 1990). New advances in mycobacterial molecular genetics in 
the last few years (Jacobs etal., 1991; Barletta etal, 1990; Cirillo et 
al., 1991) have opened up the possibility of applying new 
technologies to the direct manipulation of M. paratuberculosis. This 
may result in new and more effective vaccines, a more 
comprehensive understanding of the pathogenesis of M 
paratuberculosis, and the development of new diagnostic tools. 
This work has focused on the cloning and characterization of 
gene expression signals from M. paratuberculosis. We have 
demonstrated that pJJ2, a promoter selection vector, can be used to 
clone bacterial promoters in £ coli. To test this vector, several novel 
promoters from M. paratuberculosis were cloned. One of these 
96 
transcriptionally active constructs (pTB28) was sequenced and 
shown to contain potential -35 and -10 promoter regions that closely 
resemble the consensus promoter sequence established for 
mycobacteria in this study. In addition, a previously characterized 
M. paratuberculosis promoter sequence was cloned into pJJ2 and 
shown to express the galK reporter gene.. This enabled a direct 
comparison of promoter selection abilities in pJJ2 versus the parent 
vector pKOl in E. coli. 
Nine novel M. paratuberculosis promoter-containing fragments 
were identified and sequenced from a DNA library cloned in pYUB76. 
Expression of the reporter gene lacZ was measured transcriptionally 
by slot blot hybridization analysis with steady state RNA from M. 
smegmatis, and translationally by p-galactosidase assays. The 
transcription start sites were experimentally determined for eight 
promoters and their sequences were aligned relative to the start 
sites. From this alignment, a consensus nucleotide sequence for 
mycobacterial promoters was established. 
During these studies, at least two strong M. paratuberculosis 
promoters (pAJB300 and pAJBSOS) were isolated when an initial 
selection for promoter activity was performed in M. smegmatis. 
These same constructs show no p-galactosidase activity in E. coli. The 
strength and specificity of these promoters make them excellent 
potential candidates for production of recombinant antigens in BCG. 
These data provide the impetus for several new studies of gene 
expression in mycobacteria. 
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APPENDIX A: SEQUENCES UPSTREAM OF LACZ IN THE 
pYUB76::/acZFUSIONS 
I l l  
GATCTGGCTCAAGGGTCCGCTGGTCXTCGGGaX^GGCGCCATCCAGCTGGTGTrGCTGGCCCr 
GACCGTGGTGATCTCGACGCCGGTGGACCAGATCGAGTTCAAGACCCTGACGCTGGCCGACC 
-35 
+1 
TCGGCGGGCAGCCGACCGCGCAGCGGTGCACGGTGGCGATCTGGCGGCGCTGCGGGACCGGG 
-10 
TCACCCGGCrGGCCAGGGATITCGCGCTGTACGAGGGCGTGGAAGACTGGGCGCTGGTGGGCG 
GGTAGCCGGCCGCTGGGGACCAAAGTCACCACnTGCCCGCGGCGGCGCGGACGATTTCACG 
AACCTGTGTACGCAAGTTACAGTTATCTCG MS GCC GAA AGA CGT GTC GCT AAT ACG 
RBS Met Ala Glu Arg Pro Val Ala Asm Thr 
CTG ACG CTG GAA GTC GAG CCG GTT GTC GAA GCC AAC ATG GAT GCC GTC GTT TTA 
Leu Thr Leu Glu Leu Glu Pro Val Val Glu Ala Asn Met Asp Pro Val Val Leu 
CAACGTCGTGAC 
Gin Arg Arg Asp 
Figure lA. Nucleotide sequence upstream of lacZ in pAJB300. The 
lacZ and initiation codons are underlined. The potential 
ribosome binding site (RBS), -35, and -10 regions are 
indicated beneath the bolded sequence. The 
transcription start site is indicated by a +1 above the 
underlined nucleotide. A stop codon is indicated by 
three above the sequence. 
112 
+1 
GATCTGGCGGGCGGTCCAGTACACCGCGAGTTCGCGCACGCTGGCCGGCAGCGTCTTGGAC 
-35 -10 
GCCCGGTCGACCAGGGTITCATGCACGGCGCTGGCGACGATCAGCCTGCG GIG MG CGG 
RBS Val Met Arg 
GGG GAC GGC GAA CGG TTC GGG AAC CTG GCC GTA GCG CCG CTT GGC GAT CGA GCG 
Gly Asp Gly Glu Arg Phe Gly Asn Leu Ala Val Ala Pro Leu Gly Asp Arg Ala 
GCT GGG CAA CTT CCT GGT CGG CTA TCG ACA GTA AGC AGG GAG CCG GGC GCC TCT 
Ala Gly Gin Leu Pro Gly Arg Leu Ser Thr Val Ser Thr Gin Pro Gly Ala Ser 
AGG GTG GAG GGC GTG AGG CAC TCC CAC TCC CAC GGC CTG CCG TCG GGC CCG GCC 
Thr Val Glu Arg Val Thr His Ser His Ser His Gly Leu Pro Ser Gly Pro Ala 
CCG GTC GAT CCG GTG GTT TTA CAA GGT GGT GAC 
Pro Val Asp Pro Val Val Leu Gin Are Arg Asp 
Figure 2A. Nucleotide sequence upstream of iacZ in pAJBSOl. The 
lacZ and initiation codons are underlined. The potential 
ribosome binding site (RBS), -35, and -10 regions are 
indicated beneath the bolded sequence. The 
transcription start site is indicated by a +1 above the 
underlined nucleotide. 
113 
GATCAACACCGTGACCAGCGGGCCGAGCTGGGTGACCGCACCGAACGCGGCGCCCGCGCCGG 
ACAGATCGGCACCAACTGCCTGGCCGACGGCAGCAGCGCCATCGCCACCGCGCTCTCGGTGG 
CGGGGCCGGCCAAGATCTCGGAGTTGCCCTGCCCCAAGCCAAGTGCGTrCGTGATCTGGTCGA 
+1 
CGACGAGGGCGGTGGCGTCGCCGGTGTAGCCGAACGGCACGTGCGCGTAGGCCCAGATCGG 
-35 -10 
TGCGGTCATCGCGGNCACTGTCGTCACGGCAACTCCTGGGCTGGGCGGGCITGCGGAATCACC 
GAAAAGATAAGTGAAA ATG ATT ATC GTT ATC AGO AGG GAC CGG GAG GCT CAT 
RBS Met He He Val He Set Ser Asp Arg Glu Ala His 
ATC GAA GGC ATA GAA TTC GCT CGG TGC CGC GCT TTC GCT GCG GGC CTC GGG GGC 
He Glu Gly lie Glu Phe Ala Arg Cys Arg Ala Phe Ala Ala Gly Leu Gly Gly 
CGG GGC CGG CGG AGG CGG CCA CTA GAC TTC TGG CGT GGC CGA ATC CCC CCC CAC 
Arg Gly Arg Arg Arg Arg Pro Leu Asp Phe Trp Arg Gly Arg He Pro Pro His 
CGA GGT GCC CGA ACC GCC CGC TCG ACC CGT GTT GGT GGT CGA CTT CGG TGC CCA 
Arg Gly Ala Arg Thr Ala Arg Ser Thr Arg Val Gly Gly Arg Leu Arg Cys Phe 
GTA CGC CGA GCT GAT CGC GCC GGA CTG CGG CAG GAA CAC CAA CGC CTG CTC GAC 
Val Arg Arg Ala Asp Arg Ala Gly Leu Arg Gin Glu His Gin Arg Leu Leu Asp 
GCC GTT GTG ATA GCG CTT GAG CAT GTC GAT CCC GTC GTT TTA CAA CGT 
Ala Val Val He Ala Leu Glu His Val Asp Pro Val Yal Leu Gin Arg 
Figure 3A. Nucleotide sequence upstream of lacZ in pAJB303. The 
lacZ and potential in frame initiation codons are 
underlined. The potential ribosome binding site (RBS), 
-35, and -10 regions are indicated beneath the bolded 
sequence. The transcription start site is indicated by a 
+1 above the underlined nucleotide. A stop codon is 
indicated by three above the sequence. 
114 
GATCCGACGAACCGTGCACGATCATAGCTGTGGTCCTCGCGGCGGGTCGG'nTGTCCGAACGG 
CCGAACCCGACCAGGGTATCAGCGTGGCGAGCGGGTCGACGGTGTGGGCGCCGGCGACGGCC 
AGCGCGGTGGACCCGTCGACGATGCGGGACAACTCGGGGCCCAGTCCGCCGACCGCCCGGTTG 
GTCTCGTCGATCTGGAGCGGATGGTCAATCAACGGCAGTrCGTCGCGGCGCTGCTGCACCGTGC 
GGNCAGCCCCACCGTCTGGCTCAACCCGTGGCGCTGGTACGCGGCGCCGCGCGCGGTCGCCGAC 
GCGCTGACCGTGGACCGCGCCGACCACGCCrGGGACCTGGCCCGGCTCGGCTGGGCGCTNNAC 
GGCTCCCCCGCCACGGTGACGGTCCCGATCGGGCCGCrGTGCAGACCGCnTGCGTCGTrAGAC 
GCITATCCGGGGGTGGTGTGGGCATACTGACITACATGCGCTCCATCTGGAAGGGTTCCATCG 
CGTTCGGGCrGGTGAACGTCCCGGTCAAGGTGTACAGCGCGACCGAAGACCACGACATCAAG 
+1 
TTCCACCAGGTACACGCCAAGGACAACGGCCGTATCCGGTACCAACGGGTGTGCfiAGCTG 
-35 -10 
GACGGGGAGGTCGTCG ^ ATC GAG GCC CTG GAT CCC GTC GTT TTA CAA 
RBS Met He Glu Ala Leu Asp Pro Val Val Leu Gin 
Figure 4A. Nucleotide sequence upstream of IRCZ in pAJB304. The 
la.eZ and initiation codons are underlined. The potential 
ribosome binding site (RBS), -35, and -10 regions are 
indicated beneath the bolded sequence. The 
transcription start site is indicated by a +1 above the 
underlined nucleotide. 
115 
GATCCGCAGGACTGCGTCrGCGCGGCGGTCGCCAAGCGGCGCrACCTGGGCAAGCTGTCCGGG 
CCGCrGCTGGACCGGGTGGACCTGCGGGTGCAGATGCATCCGATGCGGGCCGGCGCGTTCGGC 
GGCGGCGACGGCGAATCCACCGCGCAGGTCCGCCGGCGGGTCGCGCAGGCGCGGCAGGCCGCG 
GCGCAGCGCrGGCrGCCGTACGGNnTCGCACCAACGCCGAGGTGAGCGGGCCGCrGCTGCGC 
CGCAAGTTCCGGCrGGGCAGCGCGGCGATGGATCTGTTCGAGGTGCGGCCCGACGGGCAGGAC 
CGGTTCACCGCCGACACCGCCGGTGATATCGGGGCCGGGGGCGACGAACGCCAGGTGGTCGA 
GGGCACCCAGGTGCTCGCGCAGGCGATCCGGACGGGCAGTrGTTGGAGTTTCTGTCGGACGG 
-35 
+1 
TTGGTTGGCGGCATirCCGGCGAGGCCGTATTCGGTCGGCCGGATGCGGGCGACAAGGCAA 
-10 
TGTTGTCGGTACCGGATGAGATGGTCTCTTC MG GAG ACG GCG CTC GGT CGA AGC GAT 
RBS Met Glu Thr Ala Leu Gly Arg Ser Asp 
GCG GTC GTT TTA CAA CGT 
Pro Val Val Leu Gin Arg 
Figure 5A. Nucleotide sequence upstream of lacZ in pAJB305. The 
lacZ and initiation codons are underlined. The potential 
ribosome binding site (RBS), -35, and -10 regions are 
indicated beneath the bolded sequence. The 
transcription start site is indicated by a +1 above the 
underlined nucleotide. A stop codon is indicated by 
three above the sequence. 
116 
+1 
GATCGGTGTGCCGCTTGAACCGGCCCAGCTCCCGCTCCAGGGTGACGIGCTCGAGCrCGGT 
-35 -10 RBS 
GTG CGC GGT GAT GAG GAG CAT GGC GGC GGG CGG CTC GTA GAT CCC GTC GTT TTA 
Val Arg Gly Asp Glu His His Gly Ala Gly Arg Leu Val Asp Pro Yal Val Leu 
CAA 
Gin 
Figure 6A. Nucleotide sequence upstream of lacZ in pAJB73. The 
lacZ and initiation codons are underlined. The potential 
RBS, -35 and -10 regions are indicated beneath the 
bolded sequence. The transcription start site is 
indicated by a +1 above the underlined nucleotide. 
117 
GATCAGGTrGCGGGTGGTTTCGTTGCCGGCCACCAGCAGCAGAAAGGCGAAGTTGAGCAGGT 
CrrCGTCGGTCAACCGGTGCTCGTCGATCrCGGCCrCGGCCAGCACCGAGAGCAGGTCGGCGCG 
CGGTCGCGCGCGGCGTGCCGCGATCAGCCGCrGGAAGTACTCGTAGAGTrGCCCGGCCGCCACC 
GCCGGGTCCAGCrCGATCTCCGGGTCGGCCGTCCCGGTGGCCGCATCCGACCACGCCCGGAATT 
GCrCCCAGTCGTCGGGCGGGGCCCCGATCAATrCGGCGATCATCCGGGTGGGCAGGGGAGCGG 
TGATCTGTrCGGTGAACTCGTGCACGGCGCCGNGTTCGATGGCGTCGAGAATGNCGTNTACG 
ATCTrGCGGATCrrCGGTrCCAGCACCGAAACACGCCGNCNGNTGAATCCGGAGTrGATCAG 
CTTGCGTAGCTGNCGGTGNCGNGGCGGATCGGTGAAGATCAGGCTGCCCTGTrGCACCGGGTr 
GGNCAGrrGCGGATCCNGNCATCGTNATGCCCCGGNTCGAGGTGAACAGAGNCGGATTGTr 
TCGACACGAACCGGATGTCCTCGTATTTCAGCAGCGCCCAGNAGITGGTGACGTCGTrGCAGC 
ACAACGGTrGCCGTTCGNGCGNAGNTrCNCGNNTAGGCGNGNATAGGGGGTrTACCCCTCNT 
CGGAAGTCCCGGNGNAATGCAAGCTGTAANGdTGGNCNANCNCAGNCNGCGAGTTTGAN 
TCnTAACGGCAAACCCCCCTCTTCCGGAGGAAAACCCGCAATCCCGACAGAATTGGGTrCA 
GGTGGGCCTAAAGTAGNGGATANCTCGAnTTCACTCGAAGGATGATTGNCGGNCNANAC 
GNGGGGGGTATACACCGAGTGATCAAGATGACCGGAGGAANCNAANATGTCCGATCCCAN 
CCGCTGTTGTCCAGACCrACCAGCrCTACATCGACGACCAGTGGGTCGAGCCACAGGACGNTC 
GGTACGACGANCTGTGTCCGTCCNCCGAGGCCGTCATCGCCACCGCANCCGACGGGAGTGTGG 
NNCAGGTCGACGACGCGATACGCGTCCGCACACCGCGCCTrCGACAACGGNCCGTGGGGCCG 
GATGTCCGCCGAGCAGCGCGCCCGGTGTCTGAACCAACTGGGCGAGGCGCTCACCAAGGACA 
CCGACGACITGNTCGCGCTGTCCCAAACGGAGTGGGGCTGCATCGGCAACGAGCGCATCATr 
+1 
AAAGATCGANGGCGCCGGGNTCATGTCCCTTCACCCCGCCCAGCTCGCGACCCAAGTGGTC 
-35 -10 
GACCAGGAGGTCGCCGGCATCAGCGCCGGCACGACGTrGTrGCGGCAC filG GGG CTG GGG 
RBS Val Pro Leu Gly 
GTG GTA GGG GTG CTC ACA CCC TGG AAC TTG GGG GAG TGG CTG AAG GTC ATG AAG 
Val Val Ala Val Leu Thr Pro Trp Asn Leu Pro His Gys Leu Asn Val Met Lys 
CTG AAT CAT GGG CTG GCC GCG GGG AAA ACG GTC GTG CTC AAA GCG TCT CCG CTG 
Leu Asn His Ala Leu Ala Ala Gly Lys Thr Val Val Leu Lys Pro Ser Pro Leu 
ACA CCG CTG GCC GGG CTG GCG CTG GCG GGG CTC ATG GAG GAG GAG ACG GAC ATG 
Thr Pro Leu Ala Gly Leu Ala Leu Ala Arg Leu lie Asp Glu His Thr Asp lie 
CCG CCG GGG GTG GTC AAC GTC GTC ACG CCC TGG GGG GTT GAG GCG GCC AAA CTG 
Pro Pro Gly Val Val Asn Val Val Thr Pro Ser Gly Val Glu Ala Ala Lys Leu 
CTC ACG ACG GAT CCC GTC GTT TTA CAA 
Leu Thr Thr Asp Pro Val Val Leu Gin 
Figure 7A. Nucleotide sequence upstream of lacZ in pAJB125. The 
lacZ and initiation codons are underlined. The potential 
ribosome binding site (RBS), -35, and -10 regions are 
indicated beneath the bolded sequence. The transcription 
start site is indicated by a +1 above the underlined nucleotide. 
118 
GATCGTACGGTAAATGAGTGGAGGTAAACATGGAAGCGGCTCAGCTCGCGGCAAGAGAGA 
TTAGCGACGGCCCGTGGCCGGAGACCGGATTCGGCTGGTACGAGCAGGCGACGGGTrGTCGGG 
TCACCGCGTCGACGCCGGAAGCGGAGCCCGAATTGTGGAATCAATATCTGGACGGCGCACTC 
GAGAGTrATCGCAAGCACGGCCTGGACTGGGTGCTCGACCTGGAGGGGATCAGGGATGGCGC 
CGACACGGGCCrGTrcnTGCCGCGCITGACCCCCAAGGTCGGGTCGTCGGGGGGACGCGGGTG 
GTGGGGCCGTTGCGGTCTCCGGAGGATrCGCACGCCCTGCAGGAGTGGGAAGGAAACCCGGG 
GdTCCGCTGGTGCGCrACATGATrGCCAACCGGATTCCCnTGGCGTCGTGGAAGTGAAAAG 
CGCATGGACGAATrGCCGCGAATACGGCAATCGGGCGCnTCCACCGTGCTGGCCCGCACCGC 
GTTGTCGACGATGACGCTGCTCGGTGCCCAGTTCGTCATGGCCACCGCGGCGGNGCACGTGCTC 
GAGCAGTGGCAGTCCrCCGGCGGTGTGGTGGTGTCrCGGGTGGCGNCGGTGGGCTATCCCAAC 
GAGAACTTCCGAACCATGGTGATGT TAAGGGCCATCAAGGAATACCACACGGGTGGT 
AACAAGGTTCTCGATGCGGGCGGAGCCGTCACCCGGGTCACCCTGGGACCCAGGTGGCrGATT 
TCACCGATCGTnTGGCGACGTCCCCGCAGGGCATCCGCGACATCGTCAGCGTGCGGGAGGGTr 
CGATTGACAAGACGAGCACGGTAGCCACCGAGGTGCGCCGACTGCTCGGTCCGAACCTGTTCG 
TCCrGCCCCACACCGAGTGGTTGCCGCGCCGACGCACCCTGCAACCGGTGTrCACCCGTCAGCG 
TGTCCGTGAGTITGGGGGACACATGTCCGAGACCGCGGAGAGCGTGTGCrCCGGGTGGCCCGA 
AGACACCGAGATCGACCTGGATGCACAGTGCCGCACACTGACCITGCGCGCGCrGGGCCGCrC 
GGTATrGGGnTGGACCTCGACGAGCGCTCCGACGCGATCACCGAGCCCCTGCGGGTGGCGAC 
GAGGTACGCGGTGCGGCGGGCGCrGCGGCCGCTGCGCGCACCGGAGTGGCTGCCCACACCGTCG 
CGGCGGCGCGCCCGCGCCGCGGCCGGCGCCATrCGCGCGCTGGGGGATGAGATCCTGCAGGCGT 
GCCGCGCCGACCCCGACCGGGAGGCCCCGTrGGTGGATGCGGTCATCGCGGCCACCGACCCGGA 
GACCGGGCAGGCGTTGTCGGACAAGGAAATCCGCGACGAAATGATCATCTTCCTGTTCGGCG 
GCCACGACACCACGGCGACGACGCTGACCTACGCGCTGTGGGCGCTGGGCCGCCATCCCGAGT 
ATCAGGCGCGGGTCGGGGCCGAAGTGTCCGAGTrACCGGACCGCCACCTTACTCCCGATGAC 
-35 
+ 1 
GTTGCACGGCTGGGATTAACGGTCCGCGTGGICCAGGAGACACTACGACTGTGTCCGCCCG 
-10 
GGCCGACCGGAACCCGGATGGCCACCCACGATGTCGAAGTCGCCGGCrACCGGGTCGAAGCCG 
GAACCATGACTGGGGTTCGGGAGA MG GCG GTA CAA ACC GAT CCG AGG TTG TGG 
RBS Met Ala Val Gin Thr Asp Pro Ser Leu Trp 
GAG GGC CCr CTG CGC GGC GAG CCG GAT CCC GTC GTT TTA CAA 
Asp Ala Pro Leu Arg Gly Asp Pro Asp Pro Val Val Leu Gin 
Figure 8A. Nucleotide sequence upstream of lacZ in pAJB86. The 
lacZ and initiation codons are underlined. The potential 
ribosome binding site (RBS), -35, and -10 regions are 
indicated beneath the bolded sequence. The transcription 
start site is indicated by a +1 above the underlined nucleotide. 
A stop codon is indicated by three above the sequence. 
119 
TAGGCGTATCACGAGGCCCnTCGTCrrCAAGAATTCCCGGGGATCCCCGGGTACCGAGCTCG 
AATTCACTGGCCGCCTGCATCACCGGCGTCATCTGCGCGCTCATCGGTCAGCCTGGCGGCrCCG 
GCGGGdTGCGGGTCGAAGCGCAGCACCAGCCCGAAGATCAACACGATCAATCCGAACAGC 
GTGCCGAGCATGATGACAGCGCCCACGGCCGCACCCCrrCCGATCCGAGCTCGACTCATTAGA 
TAGTGCACAGTATCCTAAAGTCAACCATCGACGAGAGGACACCACGTGGCCCAGGGGCCGTC 
CAGGCGGCGGCGCGGCAGCGGCGCCGGCCTCGATCCGCCGGCCCCGCGGCGCGCCGCGCCAGCT 
GCTGCTCGACACGGCCCGGGCCCGCnTGCCCGGCAGGACTACCGAAGCACCACGACACGCGA 
AATCGCCCAGGCCGGAGGGGIM CCG AGC ATC TGC TGT TCC GCC ACT TCG GTT CCA 
Pro Ser He Cys Cys Ser Ala Thr Ser Val Pro 
AGG CGG CGC TGT TCC GCG AGG CGC TGG TGC TGC CGT TCA CCG ATT TCG TCG CCG 
Arg Arg Arg Cys Ser Ala Arg Arg Trp Cys Cys Arg Ser Pro He Ser Ser Pro 
AAT TCG AGC TCG GTA CCC GGG GAT CCC GTC GTT TTA CAA CGT 
Asn Ser Ser Ser Val Pro Gly Asp Pro Val Val Leu Gin Arg 
Figure 9A. Nucleotide sequence upstream of lacZ in pAJB60. The 
lacZ codons are underlined. A stop codon is indicated by 
three above the sequence. No typical translational start 
signal was identified and the transcriptional start could not be 
experimentally determined. 
GATCACCAGCTCCGGCTTGCCCAGCGACGACACCAGGTCGGCGAGCTTGATGTrGCGGGCCTC 
-35 -10 
CGACATGGCGCCCGGATAGAAGGAGGC GAT CCC GIC GH TTA 
RBS Pro Val Val Leu Gin 
Figure lOA. Nucleotide sequence upstream of lacZ in pAJB89. The lacZ 
codons are underlined. No typical translational stop or start 
signals were identified for this sequence. The potential -35, -10 
and ribosome binding site are shown in bold. 
120 
APPENDIX B: NUCLEIC ACID BLAST HOMOLOGY RESULTS 
121 
BLAST Search Results 
PATB89: % Recoention 
>gblU17898IBSU17898 Pseudomonas solanacearum Positives = 31/38 (81%) 
exopolysaccharide EPS I synthesis and export 
locus, epsA, epsB, epsC, epsD, epsE, and epsF genes, 
complete cds. (Length = 9382) 
>emblX16300ISVPKS Streptomyces violaceoruber Positives = 42/66 (63%) 
polyketide synthase gene cluster. 
Length = 5820 
>emblX16144ISVGRA S. violaceoruber DNA for Positives = 42/66 (63%) 
granaticin polyketide synthase. 
Length = 6793 
>emblX74768ISCCYAAC S.coelicolor cya gene for adenylate Positives = 48/80 (60%) 
cyclase. Length =1324 
>gblL13419ICVNFCCAB Chromatium vinosum tetraheme Positives = 31/42 (73%) 
cytochrome c gene, 3' end, bacterial ankyrin 
homologue, flavocytochrome c heme subunit fccA 
(complete cds) ,and flavin subunit, fccB (3' end). 
Length = 2562 
PAIB304: 
>gblM63677ISERERYAB S.erythraea second and third Positives = 60/90 (66%) 
ORF's of eryA gene, complete cds. 
Length = 20,235 
>emblX62569ISEERYABS S.erythraea eryA gene for Positives = 60/90 (66%) 
6-deoxyerythronolyde B synthase II & III. 
Length = 20,444 
>emblD13614ISGORF S.griseus genes encoding proteins Positives = 36/44 (81%) 
similar to the regulators of two-component 
regulatory systems and membrane translocators, 
complete cds. Length = 5428 
>emblX72787ISGNUSG S.griseus nusG, rplKAJL gene cluster. Positives = 32/45 (71%) 
Length = 7235 Positives = 33/49 (67%) 
Positives = 36/56 (64%) 
Positives = 32/51 (62%) 
Positives = 35/58 (60%) 
>emblX55467ISLMRO S.lividans mercury resistance operon Positives = 35/58 (60%) 
Length = 5082 Positives = 49/76 (64%) 
>gblM37378ISTMAPHE S.griseus streptomycin-3'- Positives = 51/80 (63%) 
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phosphotransferase gene, complete cds. 
Length = 2854 
>gblU02635ISLCPOL Streptomyces lividans TK64 
chloroperoxidase (cpoL) gene, complete cds. 
Length = 1903 
>emblZ19549IMTBCARBCP M.tuberculosis gene for biotin 
carboxyl carrier protein. Length = 2340 
Positives=63/112 (56%) 
Positives = 22/28 (78%) 
Positives = 49/76 (64%) 
>emblZl 1929ISCMETALLO S.coelicolor genes for metallo- Positives = 37/52 (71%) 
proteinase and LysR-type transcriptional activator. Positives = 25/35 (71%) 
Length = 4673 
>emblX62518ISCPKSGC S.curacoi polyketide synthase gene 
cluster. Length = 5469 
Positives = 39/59 (66%) 
Positives = 27/37 (72%) 
>emblX65195ISVPTT S.viridochromogenes genes pms, phsA, Positives = 39/56 (69%) 
pat and dea for phosphinomethylmalic-acid-synthase, 
phosphinothricin-tripeptide-synthetase A, 
phosphinothricin-N-acetyltransferase and 
N-acetylphosphinothricin-tripeptide deacetylase, respectively 
Length = 4053 
>emblX53527ISGAPHE Streptomyces griseus aphE gene for 
streptomycin phosphotransferase. Length = 819 
>gblM16482ISTMSMK S.griseus streptomycin 
6-phosphotransferase gene, complete cds. 
Length = 1627 
>emblX74904IGGLRPA2MR G.gallus mRNA for LRP/alpha-
2-macroglobulin receptor Length = 15,598 
>emblD13775ISLCA Streptomyces lividans chiA gene 
for chitinase A. Length = 2000 
>emblX158671MLUVRA Micrococcus luteus homolog of 
the E.coli uvrA gene. Length = 3739 
>dbjlD12470ISTMGASP S. fradiae DNA for glutamic 
acid-specific protease, complete cds. 
complete cds. Length = 2064 
>gblL13455ISTMVALDEHY Streptomyces coelicolor 
(clone pWHM1051) valine dehydrogenase (vdh) 
gene, complete cds; 3' end ORFl. Length = 3007 
Positives = 50/80 (62%) 
Positives = 50/80 (62%) 
Positives = 35/48 (72%) 
Positives = 30/47 (63%) 
Positives = 28/34 (82%) 
Positives = 49/79 (62%) 
Positives = 48/77 (62%) 
Positives =71/130 (54%) 
>gblL32017IUSMTOI Ustilago maydis topoisomerase 1 gene. Positives = 42/64 (65%) 
complete cds. Length = 3740 
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PATB303: 
>gblU00015IU00015 Mycobacterium leprae cosmid B1620. 
Length = 42,325 
Positives = 71/95 (74%) 
>emblY00142ISLXP55 Streptomyces lividans DNA for xp55 Positives = 37/50 (74%) 
protein and p49 protein. Length = 4540 Positives = 23/30 (76%) 
>gblL26338ISTMFPS Streptomyces roseofulvus frenolicin 
polyketide synthase genes, complete cds. 
Length = 5530 
>gblMl50501AMSXYLI Ampullariella xylose isomerase 
gene, complete cds; xylulose kinase gene, putative 
partial cds. Length = 1892 
Positives = 45/66 (68%) 
Positives 
Positives 
52/86 (60%) 
23/30 (76%) 
>emblX72857ISCPSCP2 S.coelicolor plasmid SCP2 DNA. Positives = 50/85 (58%) 
Length = 3267 Positives = 29/40 (72%) 
>emblZ14056IPSHRPB P.solanacearum DNA for hrp gene 
locus. Length = 18,300 
Positives = 37/49 (75%) 
>emblX55794ISAGDDPEP S.albus G gene for extracellular Positives = 49/81 (60%) 
metallo (Zn) DD-peptidase. Length = 1234 Positives = 20/24 (83%) 
>gblM77739IECOBETB E.coli betaine aldehyde 
dehydrogenase (betB) gene, complete cds. 
Length = 1854 
Positives = 36/48 (75%) 
>emblX52905IECBET Escherichia coli betT, betl, betB and 
betA genes. Length = 7412 
Positives = 36/48 (75%) 
>gblU14662IBHU14662 Baboon herpesvirus HVP2 gB Positives = 45/74 (60%) 
glycoprotein (UL27) gene, complete cds. Positives = 26/35 (74%) 
Length = 2817 Positives = 31/47 (65%) 
>gblL14320IHSBBlCP4A Bovine herpesvirus type 1 Positives = 27/33 (81%) 
early-intermediate transcription control Positives = 25/32 (78%) 
protein (BICP4) gene, complete cds. Length = 8113 
>emblZ18946IMLCGA Mycobacteriophage L5 complete Positives = 34/43 (79%) 
genome. Length = 52,297 Positives = 29/45 (64%) 
>gblU12276IBPU12276 Bordetella pertussis BrkA (brkA) Positives = 40/61 (65%) 
gene and BrkB (brkB) genes, complete cds. Positives = 48/87 (55%) 
Length = 4300 Positives = 33/54 (61%) 
>gblM64834ISTMLATACV S.clavuligerus lysine-epsilon-
amino-transferase (lat) gene, complete cds and 
delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine 
Positives = 37/52 (71%) 
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synthetase (pcbAB) gene, 5' end. Length = 2632 
>gblU12015ISCU12015 Streptomyces davuligerus lysine Positives = 37/52 (71%) 
e-aminotransferase (lat) gene, complete cds, and delta-
{L-alpha-aminoadipyl)-L-cysteinyl-D-
valine synthetase (pcbAB) gene, partial cds. Length = 4029 
>emblX597931ECRP4TRA E.coli broad-host-range IncP-alpha Positives 
plasmid RP4 traA, traB, traC-1, traC-2 & traD genes Positives 
Length = 4412 
33/51(64%) 
45/79 (56%) 
Positives = 21/27 (77%) 
>emblX62287ISCWHIB S.coelicolor whiB gene 
Length = 3488 
Positives 
Positives 
30/43 (69%) 
30/43 (69%) 
>gblM34651ISHlPR01E Pseudorabies virus with upstream Positives = 34/47 (72%) 
and downsteam sequences. Length = 15,141 Positives = 25/35 (71%) 
>gblU08602ISSU08602 Streptomyces sp. WL6 alpha-
amylase (amy) and (urf2) genes, complete cds and 
(urfl) gene, partial cds. Length = 3088 
Positives = 34/46 (73%) 
nATB3 05: 
>emblX79146ISLLlNC S.lincolnensis (78-11) Lincomycin 
production genes. Length = 36,270 
Positives 
Positives ^ 
Positives 
Positives 
37/50 (74%) 
25/30 (83%) 
30/42 (71%) 
40/65(61%) 
>gblL34880ISTMDAUABCE Streptomyces sp. aklaviketone 
reductase (dauE) gene; cyclase/dehydrase (dauA) 
gene; polyketide reductase (dauB) gene; 
oxygenase, polyketide synthase, acyltransferase 
(dauA) genes; aklanonic acid methyltransferase 
(dauC) gene. Length = 8089 
Positives = 70/120 (58%) 
>gblM37181IPSEALG76 P.aeruginosa alg76 gene, complete 
cds. Length = 2328 
Positives = 35/49 (71%) 
Positives = 33/49 (67%) 
>gblL29417IPSEGAS Pseudomonas aeruginosa (clone 
pGL2B5) gyrase A subunit (gyrA) 
gene, complete cds. Length = 3150 
Positives = 71/123 (57%) 
>gblL13455ISTMVALDEHY Streptomyces coelicolor (clone Positives = 41/56 (73%) 
pWHMlOSl) valine dehydrogenase (vdh) gene, 
complete cds; 3' end ORFl. Length = 3007 
>gblL239701AVIHOXHYP Azotobacter vinelandii hox and hyp Positives = 41/62 (66%) 
operons, complete cds. Length = 13,914 Positives = 28/41 (68%) 
Positives = 26/37 (70%) 
Positives = 39/67 (58%) 
Positives = 34/56 (60%) 
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>gblL35560ISTMDNRDPS Streptomyces peucetius 
daunorubicin-doxorubicin polyketide 
synthase (dnrH, dpsA-dpsF) genes, 0RF5 and 
0RF8. Length = 8737 
>emblX62666IPAXCPSP P.aeruginosa genes xcpR, xcpS, 
xcpT, xcpU, xcpV, xcpW and 
xcpX for secretion proteins. Length = 5940 
Positives = 68/118 (57%) 
Positives = 32/44 (72%) 
Positives = 26/35 (74%) 
PATBBOO: 
>emblX59610IAVNFRX A.vinelandii nfrX gene for uridylyl 
transferase. Length = 2790 
>emblDll 136IHHHAL Halobacterium halobium DNA for mex 
halorhodopsin, partial sequence. Length = 619 
>emblZ46913ISAPKSGENE S.ambofaciens gene for 
hypothetical polyketide gene. Length = 1664 
>emblD90223IPABRACG P.aeruginosa braCDEFG operon 
for branched-chain amino acid transport (LlV-1) 
components. Length = 5302 
>gblM28303ISTMLACBG S.albus beta-lactamase gene, 
complete cds. Length =1410 
>emblZ14056IPSHRPB P.solanacearum DNA for hrp gene 
locus. Length = 18,300 
>gblL29299IFRANIFX Frankia alni nitrogen fixation gene 
cluster (including nifX, nifW, nifZ, nifB, and nifU), 
complete cds's. Length = 4567 
PATB301: 
>emblX14112IHElCG Herpes simplex virus type 1 complete 
genome. Length = 152,260 
Positives = 70/121 (57%) 
Positives = 64/108 (59%) 
Positives = 42/62 (67%) 
Positives = 38/53 (71%) 
Positives 
Positives 
Positives 
Positives 
= 25/31 (80%) 
= 33/51 (64%) 
= 57/98 (58%) 
= 19/23 (82%) 
Positives = 47/76 (61%) 
Positives= 
Positives= 
Positives= 
53/87 (60%) 
52/93 (55%) 
18/19 (94%) 
>emblX02499IRRATP Rhodospirillum rubrum atp operon. Positives=42/63 (66%) 
Length = 8775 
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PATB300: 
splP36756|VL2_HPV30 Probable L2 protein 
Query: 5 PVANTLTLELEPWEAN 21 
P+A+T +E++P++ AN 
Sbjct: 325 PIAHTEBIEMQPLLSAN 341 
Poaltlves=14/17 (82%) 
spIP23870|HHA_EC0LI Haemolysin expression modulating 
protein 
Query; 1 MAERPVANT 9 14 LEPWEAN 21 
M+E+P+ T LE V +E N 
Sbjct: 1 MSEKPLTKT 9 24 LERVIEKN 31 
PATB301: 
Posltlves=7/9 (77%) 
Posltlves=6/8 (75%) 
8p|Q02388lCA17_HUMAN Collagen alpha l(VII) chain (Long 
chain collagen) 
12 LAVAPLGDRAAGQLPGRLSTVSTQP 3 6 
L V+P+ D A +LPG+ VS P 
379 LPVSPVTDLQATELPGQRVRVSWSP 403 
Query: 
Sbjct: 
Query: 
Sbjct; 
sp IP35569IIRS1_M0USE Insulin receptor substrate-1 
Query: 13 AVAPLGDRAAGQLPG 27 
A P G + G+LPG 
Sbjct: 552 AAYPPGGGSGGRLPG 566 
Posltlves=15/25 (60%) 
Posltlves=6/ll (54%) 
Positlves=9/12 (75%) 
34 TQPGASTVERVT 45 51 GLPSGPAPVDP 
T PG S+ +RVT GLP P P P 
878 TLPGISSSQRVT 889 1300 GLPGSPGPQGP 
61 
1310 
Posltlve8=9/15 (60%) 
Positives 15/27 (55%) 
Query: 30 STVSTQPGASTVERVTHSHSHGLPSGP 56 
S+ S P +T E+ THS G P GP 
Sbjct: 1036 SSASVTPQGATAEQATHSSLLGGPQGP 1062 
sp|P16917|RHSB_ECOLI RHSB protein precursor 
Query: 1 VMRGDGERFGNL 12 
V R D +RFG + 
Sbjct: 549 VTRYDHDRFGQM 560 
Positives=ll/19 (57%) 
Posltlves=8/12 (66%) 
Posltlve8=10/27 (37%) 
Query: 14 VAPLGDRAAGQLPGRLSTVSTQPGAST 40 
+AP G R Q V T G T 
Sbjct: 606 lAPDGSRNGTQYDAWGKAVRTTQGGLT 632 
Query: 36 PGASTVERVTHSHSHGLPS 54 
P + E+V+ H+HG S 
Sbjct: 1331 PCPNGTEKVSAYHTHGADS 1349 
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sp|P31574|PIXB_EC0LI FixB protein Positive8=20/39 (51%) 
Query: 8 RFGNLAVAPLGDRAAGQLPGRLSTVSTQPGASTVERVTH 46 
R G Ii A LG R + STVS Q G +TV+ + + 
Sbjct: 54 RRGKLLAAKLGYRLKAAVSNDASTVSVQDGKATVKHMVY 92 
sp|P2869XlFTSH_ECOLI Cell division protein ftsH 
Query; 
Positive8=9/15 (60%) 
Positives=15/45(33%) 
6 GERFGNLAVAPLGDRAAGQLPGRLSTVSTQPGASTVERVTHSHSH 50 
G G P GD + S +ST G E + + H 
Sbjct: 440 GRALGVTFFLPEGDAISASRQKLESQISTLYGGRLAEEIIYGPEH 484 
Query: 
Sbj ct: 
PATB303: 
46 HSHSHGLPSGPAPVD 60 
+S +G P P PVD 
612 NSGDNGSPKAPRPVD 626 
sp|P32536|ENV_HV2S2 Envelope polyprotein GP160 precursor Positives=12/18 (66%) 
Positivea=7/13 (53%) 
PoBitivea=7/18 (38%) 
45 IPPHRGARTARST 57 
+PP G T ST 
432 LPPREGQLTCNST 444 
Query; 
Sbjct: 
27 
264 
GLGGRGRRRRPLDFWRGR 44 
G G R +W GR 
GFNGTRAENRTYIYWHGR 281 
Query: 69 RADRAGLRQEHQRLLDAV 86 
R AG+ Q+ Q+LLD V 
Sbjct: 535 RTSLAGIVQQQQQLLDW 552 
spIP33485IVNUA_PRVKA Probable nuclear antigen 
Query; 26 AGLGGRGRRRRPLDFWRGRIPPHRG 50 
AG G R RRRR D G -f P RG 
Sbjct: 1001 AGGGARRRRRRRWDDEAGLLGPERG 1025 
Positive8=14/25 (56%) 
PositiveB=12/28 (42%) 
Query: 46 
Sbjct; 1646 
PPHRGARTARSTRVGGRLRCFVRRADRA 73 
P RG R A GGR C RA A 
PSPRGCRGAGRAGGGGRGGCGGGRAPGA 1673 
sp|P18040|ENV_HV2Gl Envelope polyprotein GP160 precursor Positives=H/14 (78%) 
Positives=7/13 (53%) 
Positives=7/18 (38%) 
Query; 27 GLGGRGRRRRPLDFWRGR 44 45 IPPHRGARTARST 57 
G G R +W GR +PP G T ST 
Sbjct; 261 GFNGTRAENRTYIYWHGR 278 429 LPPREGQLTCNST 441 
Query; 
Sbjct; 
73 AGLRQEHQRLLDAV 86 
AG+ Q+ Q+LLD V 
536 AGIVQQQQQLLDW 549 
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PATB305;  
sp|P14581ICP47_RABIT Cytochrome P450 IVA7 (EC 1.14.15.3) Positive8=9/10 (90%) 
Query: 1 METALGRSDP 10 
M+T L6RSDP 
Sbjct; 105 MKTILGRSDP 114 
